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P R E F A C E .
The investigations on which this thesis is 
based were carried out by me in the Wards and 
Pathological Department of the Royal Samaritan Hospital 
for Women, Glasgow, during the years 1950-1953 while I 
was holding the appointments of Assistant Surgeon and 
Assistant Pathologist to the hospital.
I have pleasure in expressing my thanks to 
Dr. A.D.T. Govan for his advice during the writing of 
the thesis. Thanks are also due to Dr. D.M. McIntyre,
Dr. J. Hewitt and Dr. W. Clement for permission to
study cases in their wards, and to Mr. Pearston for
his assistance in the preparation of the microphotographs.
INTRODUCTION 
The cyclic changes in the endometrium during 
the reproductive phase of life, together with the 
mechanism of bleeding at menstruation have been 
extensively studied and repeatedly described 
since Hitchmann and Adler's classical researches 
in 1907# The histological appearances of the 
endometrium in functional bleeding have also 
received much attention and attempts have been 
made to correlate the endometrial pattern with 
the occurrence of bleeding. There does not appear 
to have been a proportionate interest in the 
histological structure of the post-menopausal 
endometrium; which is surprising in view of the 
serious import of many changes at this period of 
life. It seems to have been assumed that the 
endometrium, like the other genital tract tissues, 
always undergoes atrophic changes. The traditional 
conception of the senile endometrium is of a 
mucosa which has become thin and atrophic, with 
a few small inactive glands set in a sparse 
fibrous stroma. The surface and gland epithelium 
becomes low cuboidal in type and the glands are
of very small calibre.
That this was not invariably so was reported 
by Novak (1944) who described the occasional 
presence of cystic glands lined by flattened 
epithelium. He also referred to the frequent 
finding in patients long after the menopause of 
cystic glandular hyperplasia of the endometrium. 
Speert (1949) noted the occurrence of endometrial 
polypi. Mention is also made in the literature 
(Breipohl, 1935) of the finding of secretory 
endometrium. It is apparent then that the post­
menopausal state of the endometrium is not 
always one of simple atrophy.
These findings are important because in post­
menopausal gynaecological disorders, particularily 
the occurrence of bleeding, considerable emphasis 
has been laid on the appearance of the endometrium. 
The bleeding has, in fact, been related to the 
pattern of the endometrium and particularily to the 
finding of cystic glandular hyperplasia. Such a 
conclusion seems unwarranted if the findings of 
the various authors quoted above are true. Before 
any interpretation can be made of the endometrial
picture in oa®e® of post-menopausal bleeding it 
is obviously n®o§®aary to determine the various 
patterns whieh may be found in the normal post­
menopausal- patient and to asses® their importance.
It has been shown that the post-menopausal 
endometrium may be stimulated to growth by the 
presence of oestrogen in the women1s body (deist, 
1935l Novak and irawner, 1934)* 2he administration 
of oestrogen even to oastrated women will produee 
a typical hyperplasia (laufmann, 1934? and 
Zuokermann, 1937), and the ooourrenoe of hyper- 
pl§sla of the endometrium in association with 
granulosa-cell and thecoma-cell tumours of the ovary 
is good evidence of the responsiveness of the 
senile endometrium to the ovarian hormones. On 
this basis it was assumed that post-menopausal 
bleeding was always aiiooiated with hyperplasia 
and by infereno® with an txee®® of oestrogen. So 
much so that if wa® sufg©§t©d (1© bind©, 1936) 
that when hyperplasia was found long after the 
menopause, one should look for ovarian tumour® - 
perhaps too small to be recognised on bimanual 
examination - that art associated with hyper- 
oestriniem.
c;j  *
However post-menopausal hyperplasia exists 
in the absence of any such obvious source of 
oestrogenic stimulation. Moreover hyperplasia 
is not an invariable finding in cases of 
functional post-menopausal bleeding. The incidence 
of hyperplasia in the endometrium associated with 
benign post-menopausal bleeding is variously 
estimated at from 10 to 50 per cent., (Breipohl, 
1935; Novak and Yui, 1936; Payne, 1937)* In 
addition it is significant that hyperplasia may 
be present in the endometrium of a woman who has 
not had any vaginal bleeding since the cessation 
of menstruation.
It is obvious that several distinct problems 
exist in relation to the endometrium of the post­
menopausal woman. The first controversial point 
is the incidence of the varying histological 
patterns of the normal. The incidence of 
hyperplasia in post-menopausal patients with and 
without bleeding is uncertain and the significance 
of its presence is not clear. The final question 
is the relationship existing between the 
endometrial pattern and the occurrence of post-
menopausal bleeding, and the mechanism of the 
bleeding.
Hyperplasia of the endometrium is 
histologically a frankly benign lesion in most 
cases. There are a few instances however in 
which an unusual degree of epithelial proliferation 
is present, and in others the glands themselves 
may show a marked increase in number with almost 
no interglandular tissue and perhaps with very 
atypical gland involutions and convolutions.
The degree of activity may on occasion suggest 
actual adenocarcinoma of the endometrium. Such 
cases are very infrequent and represent only a 
small percentage of the total. The fact that they 
do occur has led some observers to suggest the 
possibility that the two lesions have a common 
origin and that in fact hyperplasia may be the 
forerunner of endometrial carcinoma. That natural 
oestrogens are of similar chemical constitution 
to some of the known carcinogenic substances 
raises the question as to whether the oestrogens 
may not, under certain circumstances, be involved 
in the aetiology of malignant disease of the 
endometrium. It is maintained by others, however,
that carcinoma arises in the endometrium as a 
result of causes as yet unknown, and from start 
to finish possesses its original malignant 
histological and biological characteristics.
Any relationship between endometrial hyper­
plasia and carcinoma might be assessed in several 
ways. If carcinoma is proceeded by hyperplasia 
then in such cases the uninvolved portion of the 
endometrium ought to show hyperplasia. This 
finding was reported by Novak and Yui (1936), and 
Payne (1937). Contradictory results have been 
described by Heurlin (1911); Fahlund and Iroder®
(1946)| and Jones and Brewer (1941), who found 
the associated endometrium to be atrophic in most 
cases.
Similarily if post-menopausal hyperplasia 
of the endometrium is a precaneerous condition then 
a follow-up study of such patients should show a 
significant number of cases developing 
endometrial cancer as described by Bigo, Scipiades 
and Vacyz (1950). Hintze (1929) and Winter (1950) 
on the other hand did not find this to be the case.
This is a matter of extreme clinical 
importance in the treatment of patients beyond the
menopause where at curettage hyperplasia of the 
endometrium is discovered. If the histological 
picture is frankly benign, as it is in most cases, 
and if there is no close relationship between 
hyperplasia and carcinoma, then it would seem that 
curettage would, in addition to supplying the 
diagnosis, constitute adequate treatment. If 
however hyperplasia is to be regarded as a pre- 
cancerous condition in a large proportion of cases 
then more radical surgery is indicated, and 
hysterectomy would be necessary. The gynaecologist 
would require to be convinced beyond reasonable 
doubt of the malignant potentiality of hyperplasia 
before abandoning the more conservative approach 
to the treatment of post-menopausal hyperplasia 
of the endometrium.
Thus a study of the literature on the subject 
shows considerable difference of opinion as to the 
normal variations of pattern in the post-menopausal 
endometrium. The manifestations of hyperplasia, 
whether generalised or focal, as in a polyp, do 
not appear to have received adequate attention and 
their significance is as yet unestablished. The 
interpretation of the significance of the finding
of polypi is not clearly established. The 
incidence of hyperplasia in patients suffering 
from bleeding is the subject of diverse view and 
its relationship to bleeding is not uniformly 
interpreted. The final question is the possible 
link between endometrial hyperplasia and 
carcinoma.
There are two additional points of minor 
importance in connection with the thesis but of 
major clinical importance. One refers to the 
state of nutrition of the vagina in patients 
suffering from endometrial carcinoma. The presence 
of atrophic vaginitis, suggestive of oestrogen 
deficiency, in such cases is an anomalous finding 
in view of the current belief that carcinoma is 
preceded by hyperplasia which in turn is related 
to hyperoestrinism. The treatment of hyperplasia 
and its efficacy as shown in a follow-up is of 
interest in that it throws light on the nature 
of the hyperplasia.
olCTIUN 1 
IOHMaN -PQuf-MEN QP AU3AL ENDOMETRIUMt
At it varying time after tha iiianOpausb the 
©nd^ SlitPittiii is deprived of the stimulation of 
©@§ir©g§n and in Many cases bee©mss thin and atrophi 
If has been noted by some observers however that in 
©ePtain instances the endometrium is relatively 
abttMant* Payne (1937) found post-menopausal 
fe|ffSPfiSsia in 38 cases, in 25 of which there was 
n§ @i§Vi§us source of oestrogen. In one third of 
this §§ries there was no history of bleeding after 
the ifi§fi©pause. Novak and Richardson (l94l) studied 
the? Sndometrium from 78 post-menopausal women in 
who®.bi@eding was not a symptom. They noted the 
f§ii§Wifig endometrial patterns: atrophy 33 times,
^retrogressive hyperplasia” 25 times, hyperplasia 
lb fimeS and proliferative on 4 occasions. The 
term ''retrogressive hyperplasia” was applied to an 
endometrium showing a^Swiss-cheese" pattern but 
Where the appearance was inadtive. Gianaroli 
(1-94-7) reported the frequent finding in the post­
menopausal endometrium of cystic glands, sometimes 
uniformly present but in 15 per cent, of cases
orowdod into a localised area or the cavity, 
©specially near the fundus of th© uterus, forming 
polypoidal growths. Sp@@rt (1949) examined 60 
uteri removed from patients whose only gynaecological 
abnormality was a prolapse. &e found eystio glands 
in 72 per cent., and in 16,6 per cent, of eases an 
endometrial polyp containing distended gland© was 
present.
Materials
ooeeimena obtained by curettage^
In the first instance an analysis was mad© in 
1521 post-menopausal patients not suffering from 
bleeding who had been curetted in the loyal 
Samaritan Hospital for Women, Glasgow, Gare was 
taken in the selection of the type of case studied 
and all oases of functional disorder were eliminated. 
Only cases where the patient was aged over 40 year© 
and with a history of amenorrhoea for at least a 
year were included in the investigation. In most 
cases the patient suffered from prolapse and routine 
curettage was performed before operation for th© 
cure of prolapse was undertaken, The complaints 
from which the patients suffered w@r©.4-
Prolapse 1503
Abdominal pain 10
Abdominal swelling 4
BacAache 4
Findings
In 1315 cases no material beyond a little 
mucus was obtained at curettage. The total number 
of cases where curethings were available for 
examination was 206 and trie incidence of the 
endometrial pattern is shown in Table. 1. In one 
instance there was a tuberculous infection of the 
endometrium and the glands were so fragmentary it 
was impossible accurately to allocate it to one of 
groups.
Table 1
Endometrial pattern in curettage specimens.
Type
of
Endo­
metrium
Inactive 
dilated gland Hyper­
plasia
Pro­
lifer­
ative
Fibro 
Adeno­
ma tojs 
PolypAtrophic Polyp Diffuse
No. of 
Cases 65 80 8 26 12 14
Percent­
age 31.7 39.0 3.9 12.7 5.3
COKO
1* Atrophy. A histological diagnosis of atrophy 
of the endometrium was based on the finding of a 
thin mucosa with few small glands in a fibrous
stroma. The diameter of the glands was in the 
neighbourhood of Q.l millimetre and the average 
thickness of the endometrium was 0. 4 millimetre.
The gland epithelium was low ouboidal in type 
and inactive in appearance. The histological 
appearance of the atrophic endometrium is shown 
in Fig.1.
2, Inactive dilated gland pattern. Two varieties 
of this change were found. In 80 cases the 
appearances were confined to a single polypoidal 
portion of the endometrium and in the remainder 
the condition was more generalised and diffuse.
Where a polyp was present the size varied 
considerably - the largest noted being 1" x  $■" x -J-". 
This condition was diagnosed when the mucosa 
showed marked cystic dilatation of the glands, 
the diameter of which varied greatly but was 
frequently about 1.5 millimetres, only about six 
such glands being present in the average low-*power 
field. The cells lining the glands were 
flattened and inactive in appearance. The glands 
frequently contained amorphous material of a 
mucoid nature and disintegrating epithelial cells 
were also present in many cases. The stroma
Figure 1.
Is m i k
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Atrophic Endometrium. 
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stained pink with eosin. It was rather less 
cellular than that characterising the child-bearing 
years, and the cells were spindle-shaped. Ho 
structures recognised as spiral arteries were seen 
but thin-walled veins and dilated capillaries were 
present, some of them just beneath the surface 
epithelium which was low-cuboidal or even flattened. 
This pattern is illustrated in Figs.2 and 3.
3. Active hyperplasia. Active hyperplasia of the 
endometrium was characterised by an increased 
thickness or endometrium with numerous glands and a 
very cellular stroma. The glands showed a marked 
variation in size with dilatation in some, similar to 
that seen in the active phase of metropathia 
haemorrhagica. They were considerably smaller 
than those seen in the inactive gland pattern, 
varying in diameter from 0.2 to 0.5 millimeter, 
the endometrium being up to five millimetres thick.
In the average case about 20 glands could be found 
in a low-power field. The glands were lined by a 
tall columnar epithelium with basophil cytoplasm 
and large nuclei. There was enlargement of the 
stromal cells and the cells of both glands and stroma 
showed frequent mitotic figures. It differed from
Figure 2.
'^^M:
polyp
Inactive dilated gland pattern ~ diffuse.
The glands are cystic and lined "by flattened epithelium,
H $ S x 50c 
Figure 3.
Similar histological appearance to the diffuse variety. -
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cystic glandular hyperplasia of the reproductive 
period in that areas of stromal haemorrhage and 
necrosisvere absent. In some cases cystic 
dilatation of the glands was not a prominent feature 
and the glands, tended to he closely packed together 
with little intervening stroma. Of the 26 cases 
showing this pattern a polypoid arrangement was 
noted in 7 instances. The microscopic features are 
shown in Pigs.4 and 5.
It is important at this stage to differentiate 
the appearances of polypoid active hyperplasia from 
these found in polypi of the inactive type. The 
latter are usually very much larger and in most 
instances occur singly in the uterus. The glands 
are on the average more than three times as large as 
those seen in active hyperplasia. Moreover the 
general sppearance is one of inactivity, there being 
an absence of mitotic figures in both gland and 
stromal cells. In most cases the senile polyp is 
the only tissue removed at curettage. In active 
hyperplasia, however, several polyps may be removed 
together with hyperplastic endometrium which represents 
the rest of the endometrial lining of the uterine 
cavity.
Figure 4*
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Cystic glandular hyperplasia.
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Figure 5*
Glandular hyperplasia - adenomatous pattern.
H & E x 75
Figure 6.
Mitotic figure in gland epithelium in cystic 
glandular hyperplasia.
H & E x 700
4* Proliferative endometrium. Proliferative 
endometrium similar to that seen in the endometrium 
removed in the first half of the cycle from a 
woman of the reproductive phase was observed 12 
times. Mitotic figures were present in this 
endometrium but it lacked the disparity in the 
size of glands seen in the previous type. The 
glands were about 0.2 millimetre in diameter and 
the thickness of the endometrium was on the 
average one millimetre.
5. Pibro adenomatous polyp. The term fibro 
adenomatous polyp was used to describe polyps in 
which the stroma was abundant and had a fibrous 
structure. The cells were spindle-shaped and 
the matrix was homogeneous and hyalinised. The 
glands which are of moderate size were lined by 
cuboidal epithelium. The appearances are shown 
in Pig.7.
With such a variation in endometrial pattern 
it might be expected that a relationship to some 
factor in the patients' gynaecological history 
would be found. An attempt was therefore made to 
analyse the results according to the available 
facts.
17,
Since so many of these patients showed an 
endometrial pattern which hitherto has been 
considered abnormal it was obviously necessary to 
study their menstrual history in some degree at 
the time of the menopause. The age at which the 
menopause occurs in a women is to some extent 
indicative of ovarian activity. This factor is 
shown in relation to the different endometrial 
patterns in Table 2. It is obvious that there is 
no direct relationship between the ®e of the 
patient at the time of the menopause and the 
endometrial pattern found.
Table 2
Age of menopause in relation to endometrial pattern.
Type of Endometrium Range Average
Atrophic
Inactive dilated gland 
Active hyperplasia 
Proliferative 
Eibro adenomatous polyp
39 - 55 
30 - 55
40 - 53 
37 - 52 
42 - 55
47.8 years 
47
4b. 4 
47.3 
49.6
A survey showed that almost all of the 
patients, irrespective of the endometrial pattern, 
had had a normal menopause with no untoward 
symptoms. In three patients the menopause was 
induced by deep X-ray to the ovaries or intra-
Figure 7,
Fibro adenomatous polyp. 
E & E x 30
18.
uterine radium because of excessive bleeding and 
in a fourth bilateral ovarian cysts were removed 
and the menopause followed as a result. It can 
be seen from the distribution that there is no 
direct connection between the type of menopause 
and the subsequent endometrial pattern.
(Table 3).
Table 3
Type of menopause in relation to endometrial pattern.
Type of endometrium
JN atur al 
Menopause Radium
beep
X-ray
"Sur-'"
gical
Atrophic 64 — 1 —
Inactive dilated glanc d6 1 — 1
Active hyperplasia 25 — 1 —
Proliferative 12 — - —
Pibro adenomatous pol^p 14 - - -
In view of the profound changes in the 
reproductive tract associated with pregnancy and 
parturition it was felt that a study of the 
reproductive history of these patients was indicated. 
It will be seen from Table 4, that there does 
not appear to be any significant association 
between the type of endometrium noted in the 
post-menopausal woman and her reproductive 
history.
19.
Table 4
Parity in relation to endometrial pattern.
Type of Endometrium Unmarried
Married
but
Nulliparous
Parous
Atrophic 2 6 57
Inactive dilated gland 2 12 74
Hyperplasia - 3 23
Proliferative 1 1 10
Pibro adenomatous polyp - - 14
Age after menopause
Curettage in these patients was performed
from one to 34 years after the cessation of menstrua^- 
tion. As an endocrine imbalance may be present during 
the menopause it was considered important to relate 
the length of time after the cessation of menstrua­
tion at which curettage was performed to the 
endometrial pattern found.
Table 5
Time after the menopause and endometrial pattern.
Years after 
the meno­
pause
Atrophic
Inactive
dilated
gland
Hyper­
plasia
Prolif­
erative
Pibro
adeno­matous
polyp
1-5 years 31.8 23.1 27.5 12.1 5.5
6-10 " 37.2 53.5 - 2.3 6.9
11-15 " 27.6 58.6 — - 13. 8
16-20 " 24.1 65.5 3.5 - 7.
20+ 38.1 69.1 - - -
inactive dilated gland
Polyp Diffuse
21.9 2.2
48.8 4.7
51.7 6.9
58,6 6.9
61.9 
___  ...
-
It will be seen from the table that most 
cases of hyperplasia and proliferative endometrium 
occurred in the first 5 years after the menopause. 
The inactive dilated gland pattern, both in the 
diffuse form and where a polyp was present, was 
not so frequent in the early years after the 
menopause but occurred in a larger proportion of 
cases in the later years after the menopause.
2. Specimens obtained by hysterectomy.
In order to amplify my observations the
endometrium in the excised uterus was studied.
It is obvious the removal of the uterus in the
absence of functional gynaecological disorder is
unusual and only six cases were available for
study. The patients who were submitted to
hysterectomy complained of the following symptoms:-
Prolapse 3
Abdominal pain 2 
Abdominal swelling 1.
In 5 cases the endometrium was found to be 
atrophic and in the remaining uterus a polyp 
containing inactive dilated glands was present.
3. Specimens obtained post-mortem.
While a larger number of intact uteri 
removed at operation might have been obtained from 
other institutions for study it was felt that 
no useful purpose would be served. The majority 
of such specimens are derived from cases of uterine 
prolapse and it may be argued that this condition 
is not unassociated with vascular and endocrine 
changes which might influence the endometrial 
pattern. As this might give a false impression 
of the normal, recourse was had to the study of 
post-mortem material. A total of 100 specimens were 
obtained. Cardiac failure due to vascular disease, 
coronary thrombosis or hypertension was responsible 
for death in 47 of these patients. Post-operative 
death due to peritonitis or pulmonary embolism 
accounted for another 26. In 15 cases death was 
due to carcinomatosis. Six patients died of 
pneumonia, and uraemia, tuberculosis and diabetes 
were each responsible for 2 deaths. All of these 
patients were at least two years past the menopause.
None of them had any symptoms or functional 
disturbance relating' to the genital tract.
The distribution of endometrial pattern in 
the uteri in this series is shown in Table 6,
Table 6
Endometrial pattern in intact uteri.
Type of Inacti^re dilated glands
Endometrium Atrophy Polyp Diffuse
Percentage 65 15 20
In more than half the cases in which atrophy 
was noted, an occasional cystic dilated gland was 
present, it will be seen that the diffuse cystic 
gland pattern occurred in 20 per cent, of the 
specimens compared with 3.9 per cent, noted in 
the series where the diagnosis was made from a 
study of the curettings. Polyp with inactive 
cystic glands were found in 15 per cent, of cas^ 
a much lower incidence than was found in the 
curettage series. There were no examples of 
active hyperplasia or proliferative endometrium 
in the uteri obtained at post-mortem.
Study of these specimens gave further 
information in regard to the group showing diffuse 
cystic dilatation of glands. In curettage
specimens the impression is that this type of 
endometrium is bulky but examination of the post­
mortem material snows this to he false. Although 
the cystic glands are large they form superficial 
bulges on an endometrium which, is otherwise very 
thin and atrophic. Nor do these glands extend in 
depth into the wall of the uterus. They are 
purely superficial.
The Average age/of the patients was 49.7 years, 4 were 
unmarried, 15 were married but had had no family 
and 81 were parous women.
Discussion
It will be apparent from the foregoing that 
there can be a considerable variation in endometrial 
pattern consistent with a normal post-menopausal 
history. While three of the patterns described,
i.e. atrophic, inactive dilated gland and fibro- 
adenomatous polypoidal types might be classed 
together as examples of inactivity, it is surprising 
to find active proliferation and even hyperplasia 
in the endometrium of an apparently normal post­
menopausal woman. It is perhaps significant that 
no examples of hyperplasia or proliferative 
endometrium were found in the uteri of the post­
mortem specimens. With three exceptions ill ©1 
these uteri were obtained from patients at least 
5 years past the menopause, in analysis of the 
curettage specimens reveals that with two 
exceptions, hyperplasia and proliferation were 
only found in the endometrium of patients within 
5 years of the menopause,
The term menopause which literally means 
cessation of menstruation is used also to indicate 
the transition period between the reproductive era 
and senesenoe. And ovtr a period of several years 
an otherwise normal woman may exhibit symptoms 
which are in all probability related to endocrine 
imbalance* Zondek (1934) showed that the Initial 
stages of the menopause are characterised by an 
increase in the elimination of oestrogen in the 
urine* Prank (1934) ha® demonstrated the presence 
of quite appreciable ®mount§ of oestrogen in the 
urine and in the blood of patients after the 
cessation of menstruation. It is possible that 
when endometrial hyperplasia i® found within a 
few years of the last menstrual period it is due 
to the persistence of the hyperoeetrinisa.
No such expinnjLion ©an be offered for the
single case of hyperplasia occurring 18 years 
after the menopause. It may be perhaps that the 
cause in this case was of a similar nature as on 
subsequent examination the endometrium appeared 
to be atrophic.
It will be noted from the initial analysis 
that hyperplasia and proliferation of the endometrium 
occurred with remarkable frequency in the 205 cases 
in which the curettings were examined histologically. 
The absence of examples of these types of 
endometrium in the uteri obtained at post-mortem 
suggests that these figures are fallacious and some 
explanation must be sought for the disparity between 
the two series. Although endometrial tissue was 
obtained 205 times, there was a non-productive 
curettage in a very large number of normal post­
menopausal women, and it is obvious that these must 
be taken into account in the statistical analysis.
It would seem probable that where no endometrial 
tissue was obtained on curettage the assumption 
that the endometrium is atrophic or inactive is 
warranted. If the figures for the curettage are 
analysed in the light of this the incidence of 
hyperplasia and proliferation of the endometrium
26.
is reduced to almost negligible proportions.
Table 7
Corrected figures for Table 1.
No. of
Dyne of Endometrium Gases Percentage
Inactive 1482 97.5
Hyperplasia 26 1.7
Proliferative 12 0. 8
In a consideration of the inactive types of 
endometrium there is an apparent lack of 
agreement between the incidence observed in the 
curettage series and the specimens obtained at 
post-mortem where the whole uterus was available 
for study. Where curettage did not result in the 
obtaining of endometrial tissue for examinati on 
the presence of mucus was sometimes noticed. It 
will be remembered that on study of whole uteri 
the diffuse cystic gland pattern was found really 
to be atrophic endometrium and I would suggest 
that where mucoid material is obtained this is 
due to the rupture of cystic glands by the curette. 
If this point be allowed it would appear that the 
incidence of the diffuse cystic gland pattern is 
much higher than has previously been thought. 
Instead of 3.9 per cent, it is almost certain that 
the incidence noted when the entire uterus v/as
2?»
available for study, that is y(> per ©eut. is the 
correct ore.
Endometrial polypi with oyatio dilated glands 
were found in a very high percentage of curetting® 
namely 39 per oent. This however is obvioutly 
much too high a figure, if the non-productive 
curettage cases art included in the assessment 
then the figur© fell to 5.25 p©r oent., hut if is 
possible that this figure errs in the opposite 
direction. These polypi art most frequently 
found near the fundus of the uterus as is shown 
by a study of intact uteri, and it is probable 
that in a large number of oases the curette fails 
to locate them, or at most sorapea the surface 
and draws a little mucus from the ruptured glanda. 
The percentage noted in the series of intaot 
uteri, 15, is likely to r©pr©s©nt a true incidence 
and thes© senile polypi art probably more 
frequent than is at present suspected.
The fibro adenomatous polyp may well be 
considered as a small benign tumour rather than 
an altered endometrial pattern. Its finding ig 
merely incidental and would be likely in any 
large series.
It would appear then that in any considerable 
number of post-menopausal patients the endometrium 
is likely to show a simple atrophic pattern in 
62.5 per cent., a diffuse cystic glandular pattern 
in 20 per cent, polypi with cystic inactive glands 
in 15 per cent., hyperplasia in 1.7 per cent, and 
proliferation in O.b per cent, of all cases.
The factors responsible for the varying 
endometrial patterns are obscure. A study of the 
obstetrical histories of the patients showed that 
there was no close relationship between the 
parity of the patient and the histological 
picturebf the endometrium. Similarily there did 
not seem to be any connection between the type of 
endometrium met with in the post menopausal 
period and the age at which the menopause had 
occurred or indeed the nature of the menopause.
When however the time after the menopause 
at which curettage was performed was considered 
the possible explanation for some of the changes 
became apparent. It has been pointed out that 
where hyperplasia or active proliferation of the 
endometrium was discovered, this was noted with 
two exceptions within 5 years of the menopause.
The inactive gland pattern, on the other hand, 
apparently occurred more frequently in the 
later years. This increased frequency of cystic 
glandular change in the later years may he more 
apparent than real and this question will be 
considered in another part of the thesis.
It is surprising that in all the literature 
relating to gynaecology in the past forty years 
only three communications deal with the normal 
post-menopausal endometrial pattern. Of these 
only two considered the subject as a separate 
problem. Novak and Richardson (1941) undertook a 
study of the post-menopausal endometrium as an 
incidental part of the larger subject of post­
menopausal bleeding. They studied endometriums 
from 137 post-menopausal women ; 78 were not 
suffering from bleeding. In this series they found 
simple atrophy in 45 per cent., a retrogressive 
cystic pattern in 24 per cent., hyperplasia in 20 
per cent, and proliferation in 10 per cent. The 
following table is complied from the figures 
given in their communication.
This gives a much higher incidence of hyper­
plasia than was found in my cases where
endometrium was available for examinati on.
Moreover Novak and Richardson in their communication 
took no account of cases where curettage produced 
no endometrium. As these probably represented an 
inactive or even atrophic endometrium it would seem 
that their figures of 20.4 per cent, hyperplasia 
and_J>Jj per cent, proliferative endometrium give 
an erroneous impression of the actual incidence 
of activity among post-menopausal women who have 
not had any bleeding.
TABLE 8A.
Corrected figures for post menopausal patients 
without bleeding - Novak and Richardson.
Type of 
Endo­
metrium.
Atrophic.
Pro­
lifer­
ative.
Hyper­
plastic.
Retro­
gressive.
No. of 
cases 33 4 16 25
Per cent. 42.4 5.1 20. 4 32.1
■enuume oj. rd'i pa u'treiTT— du.ro.— erne crime ax utn— m e
menopause that it was discovered is considered. 
They found hyperplasia 9 times and proliferative 
endometrium 4 times in women more than 15 years 
after the menopause. In my own series,, cases of 
hyperplasia and proliferation were, with 2
exceptions, only found within 5 years of the 
menopause.
Gianaroli (1947) in a study of intact uteri 
obtained at operation and at post-mortem failed 
to find hyperplasia of the endometrium. The most 
frequent finding was simple atrophy with cystic 
atrophy in the majority of the remainder. This 
was the description given to the appearance of 
small cystic cavities which were sometimes spread 
all over the mucosa and in 15 per cent, of cases 
crowded into one part of the mucosa forming a 
polyp. lie interpreted the cystic changes as 
evidence of a secretory activity of the endometrium. 
Reference was also made to a dilatation of the 
capillaries of part or the mucosa. He found 
telangiectasis in 2 b per cent, of cases and noted 
frequent haemorrhage into the endometrium. He was 
of the opinion that cystic and telangieetiatic 
change was the result of temporary reactivation 
of ovarian function.
Speert (1949) examined 60 uteri taken from women 
whose only gynaecological abnormality was a 
prolapse. He found cystic glands in 72 per cent, 
and in 16.6 per cent, of cases an endometrial
polyp was present. The histological description 
of the polyps show theto to he of the inactive 
cystic dilated gland pattern and the incidence 
corresponds closely with my own findings. In not 
a single case did he find hyperplasia* Speert 
also stressed the vascular pattern of these 
polyps and noted particularily the presence of veins 
just below the surface epithelium and between 
dilated glands and the surface epithelium. As he 
was frequently unable to trace a connection between 
the glands and the surface epithelium, he 
considered the cystic glands to be retention cysts.
He explained bleeding from such polyps as being 
due to rupture of a superficial cyst and 
subsequent rupture of a superficial capillary.
From my own observations and the above study 
of the literature it appears that the post­
menopausal endometrial pattern is not one of 
simple atrophy. In any consideration of pathological 
conditions related to this period of life the 
incidence of these various patterns must be taken 
into consideration.
Since this study was completed I have 
encountered a case of secretory endometrium
occurring one year after the cessation of 
menstruation. The patient aged 52 years was 
admitted for operative treatment of prolapse. 
There was no history of hormone therapy and there 
had "been no bleeding since the menopause, The 
histological appearances of the endometrium are 
shown in Fig, 8,
Summary
1* A study was made of the endometrial pattern 
of normal post-menopausal women, both in 
curettings and in hysterectomy specimens,
2. An inactive endometrial pattern occurred in 
97,5 per cent, of cases, hyperplasia in
1.7 per cent, and proliferation in 0.8 per 
cent.
3, Where an inactive type of endometrium was 
present, simple atrophy was noted in 65 per 
cent, of cases,
4^ In the remainder, cystic glands were present 
either diffusely throughout the endometrial 
lining (20 per cent.), or locally in the 
form of a polyp (15 per cent,),
5.. There was not any relationship between the 
different types of inactive endometrium and
34.
the time after the menopause at which it was 
discovered.
6. Active hyperplasia and proliferation of the 
endometriumywhen present^ occurred in the 
early post-menopausal years.
7. Inactivity is the most common condition of the 
asymptomatic post-menopausal endometrium and 
the senile endometrial polyp is probably a 
localised form of one variety of the inactive 
pattern.
Figure 8.
&§&8zM
I
•Secretory endometrium Sub-nuclear vacuolation is present 
and the stroma is oedematous.
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Section II.
THE ENDOMETRIUM IN CASES OF POST-MENOPAUSAL BEEEHING
The occurrence of bleeding in a woman some 
years past the menopause is a dramatic symptom 
and one fraught with serious danger to the patient’s 
life in many cases. fhe amount, severity and 
duration of the bleeding do not seem to be of 
great diagnostic importance. The appearance of a 
single spot of vaginal bleeding may be the first 
indication of a malignant process somewhere in 
the genital tract. And it is obvious that in an 
aging population post-menopausal bleeding will 
become a more frequent gynaecological symptom 
requiring investigation.
In many cases it is difficult to determine 
the actual source of the bleeding. In some there 
may be obvious pathological changes as in cases 
of cervical polyp, but the appearance on clinical 
examination does not always suggest that the 
source of the haemorrhage is to be found in these 
lesions. Nevertheless it is convenient to 
consider the subject of post-menopausal bleeding 
under certain headings and the cases may be 
divided into five groups as follows:-
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A. In a proportion of oases there is a malignant 
condition of the utero-vaginal tract, commonly 
of the cervix or the fundus of the uterus,
B* A number of patients have bleeding due to a 
benign condition of the genital tract outwith 
the cavity of the uterus,
0. In a few cases the haemorrhage originates in 
the uterine oeivity but some , organic lesion of 
the fundus of the uterus is present,
D, When the above causes of bleeding have been 
eliminated there remains a large number of 
patients who bleed from the uterine cavity in 
the absence of an obvious source of oestrogen and 
of any pathological condition of the fundus of the 
uterus. They may be termed cases of "functional” 
post-menopausal bleeding and it is with this 
group that I am particularly concerned in this 
thesis,
E, A small group of patients have bleeding from 
the uterine cavity and in whom there is known
to be an increase of oestrogen either administered 
medicinally or produced in the woman's body by 
a granulosa ceil or theca cell tumour of the 
ovary.
Group A - Malignant Disease.
In any case of post-menopausal bleeding, 
the exclusion of malignancy as a cause is the 
most important aspect of the investigation of the 
patient. Malignant conditions are responsible 
for a high proportion of cases of bleeding in 
elderly women. Some of the most recent surveys 
on this subject have assessed the frequency as 
about 50 per cent, of all cases of post-menopausal 
bleeding. In the present series of 2062 patients, 
a malignant condition was found to be present in 
27.8 per cent, of such cases. The most common 
site of carcinoma is the cervix and this condition 
was found in 14.8 per cent. Carcinoma of the 
fundus of the uterus was less common but occurred 
in 8.9 per cent, of the total. In a small number 
of patients, 3.1 per cent., the tumour was present 
either in the vulva, vagina, ovary or fallopian 
tube. In most cases of carcinoma of the cervix 
curettage of the uterine cavity was not performed 
and a consideration of the endometrial pattern 
found in association with endometrial carcinoma 
forms a later section of the thesis.
Group B — Bleeding from an extra uterine source.
This is a miscellaneous group including 
decubitus ulcer and pessary ulceration, senile 
vaginitis and benign conditions of the cervix, 
e.g. cervjcal polyps and erosions. Even where 
such a condition is found on exmination the 
gynaecologist, if he is wise will explore the 
cavity of the uterus to exclude the presence of 
a co-existing endometrial carcinoma. For the 
most part this was done in the cases studied and 
usually any endometrial tissue removed by the 
curette was submitted for histological examination.
In all 573 cases fell into this category.
From this series curettage failed to produce 
endometrial tissue in 474 instances. Analysis 
of the remaining 99 cases was made on the same 
basis as described in the previous section of the 
thesis. Examples of all the types of endometrium 
previously described were found and the incidence 
of each type is noted in Table 9.
As previously stated such an assessment 
must necessarily be inaccurate. The non-productive 
curettages must be taken into consideration and 
as before they must represent either cases of 
complete endometrial atrophy or of those with an
inactive endometrium contain!sag some cystic glands.
Table 9
Endometrial pattern in Group B.
Type of 
Endo­
metrium Atrophy
Inactive 
c y  tic
grands
Hyp er- 
pIasia
Hi i ro
aoeno itous 
- o!..y a
Pro­
lifer­
ative
No. of
oases 37 33 16 9 4
Per
cent. 37,4 33* 3 16,3 9 4
This fact was used in calculating the relative 
proportion of active and inactive endometrial 
patterns in normal post-menopausal women and a 
similar calculation for patients in this group
the results ahown in fat 
Table 10
)le 10.
Corrected figures for fahie 9.
Type of 
Endometrium Inactive Active
No.of cases 553 20
Per cent. 96,5 3.5
It will be seen that the incidence of hyper­
plasia and proliferation of the endometrium 
(3.5 per cent.) is slightly higher than the 
corresponding figure in the series of post-menopausal 
women who did not have any bleeding (2*5 per cent,). 
This increased incidence of hyperplasia may be
entirely fortuitous, but in some of those cases 
the obvious lesion such as a cervical polyp did 
not appear, on clinical examination, to be the 
source of bleeding. In such cases it is possible 
that the bleeding originated from the endometrium, 
which would suggest that the increased incidence 
of hyperplasia of the endometrium may be significant. 
This however will be considered more fully in a 
subsequent portion of the thesis dealing with 
this specific problem. In most instances- it would 
seem that the bleeding in patients in this group 
was actually caused by the obvious extra uterine 
lesion>and the endometrial pattern noted 
corresponds reasonably closely with that found in 
the post-menopausal woman who does not bleed.
The incidence of varying endometrial pattern 
in relation to the time after the menopause when 
curettage was performed is shown in Table 11,
Prom Table 11 it will be seen that hyper­
plasia of the endometrium was noted in one third 
of cases in the first five years after the 
menopause and approximately one tenth of the total 
in the later year groups. It should be said 
however that these percentages represent
relatively small numbers and in fact, of the 
patients whose endometrium showed hyperplasia or 
proliferation, i±,or more than half occurred 
within 5 years of the menopause.
Table 11
Time after the menopause and endometrial pattern.
Years
after
Meno­
pause itrophic
Inactive
Cystic
gland
pattern
typ er-
ulasia
Fibro-
adeno-
matous
polyp
Prolifer­
ative
Under 
5 yrs. 29.6 16. 5 33.3 11.1 7.4
6-10 42.3 42.3 3.6 3.6 3.6
11-15 36.9 42.0 10.5 10.5 -
16.-20 37*5 37.5 12.5 12. 5 -
Over 
20 yrs > 33.3 33.3 11.1 11.1 11.1
While analysis of this whole group of cases 
indicates that the distribution of endometrial 
pattern does not differ materially from that found 
in normal post menopausal women, it is conceivable 
that a change might be associated with one or 
other particular lesion. The cases formed four 
sub-groups as follows
1. A benign lesion of the cervix, either a 
polypus, an erosion or chronic cervicitis was 
presumed to be the cause of bleeding in 15*6 
per cent, of cases of post-menopausal bleeding.
A survey of the literature shows that this 
condition was noted from 6.6 per cent, to 13.9 
per cent., of cases (Te Linde 1937; Taylor and Mi lien
Cheek and Davis 1946),
In the quoted series, however, there was no 
analysis of the type of endometrium found in 
association with these lesions of the cervix. In 
my own series, curettings were obtained in 50 cases 
out of a total of 186 cases. The endometrial 
patterns found were inactive cystic glands 20 
times, atrophy 18, hyperplasia 7, proliferative 3 
and a fibro adenomatous polyp in the remaining 2 
instances. This represents an incidence of 
hyperplasia of 3.7 per cent,
2. Prolapse of the uterus complicated by a 
decubitus ulcer or pessary ulceration was noted 
in 11.8 per cent, of patients suffering from 
post-menopausal bleeding. This figure is rather 
higher than that quoted by the authors mentioned 
above, whose incidence was from 3.2 to 7.6 per cent, 
with the exception of Te Linde who noted these 
conditions in 10.7 per cent, of their cases. As 
in the other sub-groups there was no analysis of 
the associated type of endometrium by the authors.
There were 29 specimens of endometrium obtained 
for examination out of 225 cases? and atrophy was 
found 9 times, an inactive gland pattern 8, a 
fibre adenomatous polyp 6, hyperplasia 5, and 
proliferative endometrium in the remaining case, 
an incidence of hyperplasia of 2.2 per cent.
3* Senile vaginitis, when present, was characterised 
by the presence of numerous petechial haemorrhages 
usually localised to the upper third of the vagina 
and the vaginal aspect of the cervix. The 
surface bled when touched and in a few cases the 
amount of bleeding was quite considerable. This 
condition was responsible for 9.2 per cent, of 
all cases of post-menopausal bleeding. The 
incidence of vaginitis in such cases is recorded 
as from 1,6 per cent, (Jones and Cantor, 1951) 
to 11.4 per cent. (Cheek and Davis, 1946). 
Endometrium was available for study in 18 cases 
in my series out of 120 cases in all. Atrophy was 
present in 8 specimens, an inactive gland pattern 
in 5, hyperplasia in 4 and a fibro adenomatous 
polyp in the remaining 1. The incidence of 
hyperplasia was therefore 3.3 per cent,
4. The presence of urethral caruncle was observed
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in 3.7 per cent, of post-menopausal bleeding 
cases. This figure agrees closely with the 
findings of ; other writers 011 this subject who 
assess the incidence at from 11 to 4 per cent.
(Karfcor and IClawans 1932; Jones and Cantor 1951). 
There were 40 cases of urethral caruncle and in 
the two instances where the endometrium was 
examined an inactive gland pattern was found.
The incidence of the varying patterns of 
endometrium found associated with the above 
gynaecological abnormalities did not show any 
material alteration from that found in normal 
post-menopausal women. Consideration of the 
individual sub-groups might suggest that hyperplasia 
was ■unusually common in certain of them but the 
number of specimens available for examination was 
very limited, and a true picture can only be 
obtained by including cases of non-productive 
curettage. Hyperplasia was not a marked feature 
in this series of cases and as previously noted 
an active endometrium was most commonly found in 
cases within the first five years after the 
menopause. On consideration of all the facts it 
would appear that the type of endometrium found in
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those post-menopausal patients is not significant 
and that the "bleeding, almost without exception, 
is derived from the obvious gynaecological lesion. 
Group C
It is difficult to assess current opinion 
On the role of fibroids of the uterus as a cause 
of post-menopausal bleeding. Most authors dealing 
with this subject include cases complicated by 
endometrial carcinoma and many also include cases 
in which ovarian tumours and fibroids of the 
uterus occur in the same patient'* 'By calculation 
from the figures available the incidence of 
fibroids associated with post-menopausal bleeding 
given in recent literature varied from 2.6 per cent. 
(Jones and Cantor, 1951) to 6.4 per cent. (Taylor 
and Millen, 1936). In the present series I have 
considered cases in which fibroids were the only 
abnormality present. The incidence was much 
lower than that given in other reports, namely 
1,9 per cent., representing in all 39 cases.
As hysterectomy had been performed in all 
cases the endometrium was available for 
histological examination in every instance.
Analysis of the endometrial patterns is shown in
46.
Table 12.
Table 12
Endometrial pattern in cases of fibroid of uterus.
Type
of
Endo­
metrium Atrophic
Inactive
gland
Pattern
Pro­
lifer­
ative
Hyp er- 
plasia
Secre­
tory
Ho. of’ 
cases 24 6 4 3 2
Per . cent. 61.5 15.4 10.3 7.7 5.1
Only one report deals with the histological 
endometrial findings in association with fibroids 
in cases of post-menopausal bleeding. Taylor and 
Millen (193b) give an account of 2 3 cases but^f 
these 14 must be excluded because of other possible 
sources of bleeding. Eight of their cases had an 
accompanying ovarian tumour, four had a complicating 
prolapse while in two instances cervical polypi 
were present.
To date emphasis has been laid mainly in the 
anatomical position of the fibroid and little 
attention has been paid to the associated 
endometrial pattern. Te Linde (1941) while not 
providing figures, suggests that where post­
menopausal bleeding occurs from a fibroid uterus 
the site of the fibroid was the important factor.
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He considered that a submucous fibroid might 
actually become polypoidal in the post-menopausal 
period. In 12 of the cases of Taylor and Milieu's 
series the fibroids were submucous and two in the 
series reported by Cheek and Davis showed polypoidal 
fibroids, Lund and Dougherty (1950) also refer 
to the submucuus position of the fibroid and 
suggest that the bleeding arises as a result of 
necrosis, Geiger (1941) reported 11 cases of 
fibroids associated with post-menopausal bleeding. 
Most of these were submucous and a few were 
pedunculated and presented on the cervical canal.
In the present series of 39 cases only 3 were 
polypoidal. *
Nevertheless it is xDOssible as some authors 
suggest that the mere mechanical presence of a 
fibroid may induce bleeding. Fibroids even when 
intramural frequently distort the uterine cavity 
and cause an increase in the surface area of the 
endometrium. This of itself would provide a 
greater surface from which bleeding could occur, 
but it does not necessarily initiate a bleeding 
process. It is understandable that in a patient 
during the reproductive phase of life when the
endometrium is subject to cyclical stimulation 
and variations, such an increase in surface area 
would tend to increase the menstrual loss.
Fibroids, however, are not invariably associated 
with abnormal bleeding even in the reproductive 
period. This suggests that the cyclical stimulation 
of the uterus in those cases where excessive 
menstruation is a feature is at least as important 
as the presence of' a fibroid. In other words 
the fibroid tumour, per se cannot be considered as 
a direct cause of the uterine bleeding. That this 
is so is seen in the post menopausal era. Many 
patients have fibroids of the uterus and do not 
suffer from bleeding, their only complaint being 
of a swelling of the abdomen. Where bleeding occurs 
some additional complication must be present. In 
a number of cases this may be a polypoidal 
condition of the tumour with subsequent 
circulatory disturbance but in others the 
possibility of a functional upset must be considered. 
If the cases of fibroids complicated by the presence 
of an ovarian tumour, prolapse and cervical polypi 
are eliminated from Taylor and Millen's series 
then we find that hyperplasia of the endometrium
49.
was encountered in almost 15 per cent, of cases.
An active endometrium was found in 23 per 
cent, of our cases, 7 per cent, of the total being 
hyperplastic. This suggests that the endometrium 
was subject to abnormal stimulation in these 
cases. There remains however the difficulty of 
explaining the mechanism of bleeding in those 
cases where the endometrium was atrophic. This 
question will be left to be dealt with in a later 
part of the thesis where the endometrial pattern 
in cases where the uterus is known to be under the 
influence of a specific stimulation will be 
considered.
Group D - "Functional1 post-menopausal bleeding.
When the cases of post-menopausal bleeding in 
which there is an extra uterine cause for the 
bleeding and those in which there is some pathology 
of the uterus or ovary present are excluded, there 
remains a group of cases which may be termed 
functional post-menopausal bleeding. This is a 
most interesting group since a study of them may 
be the means of providing a reasonable inter­
pretation for the endometrial changes in other groups. 
There were 537 such cases in this series. No
endometrium was found at curettage on 196 
occasions. The variation in endometrial pattern 
in the remainder is shown in Table 13.
Table 13
Endometrial pattern in functional postmenopausal bleeding
Type of 
Endo­
met­
rium Atrophy
Inactive
gland
pattern
Hyper­
plasia
Pro­
lifer­
ative
P. A.
Polyp
Secre­
tory
Total 
No. of 99 62 110 25 15 6
cases
Per
cent. 29.2 24.2 32.4 7.3 4. 4 2.4
Eollowing the procedure adopted previously, the
non-productive curettages may be taken to represent 
an atrophic pattern with or without cystic dilated 
glands. The relative numbers of active and inactive 
patterns may be assessed as shown in Table 14.
Table 14 
Obrrected figures for Table 13.
Type of 
endometrium
Ho. cf 
Cases Percentage
Inactive 394 73.4
Hyperplasia 110 20.5
Proliferative 25 4. 6
Secretory 6 1.5
It will be seen from the above table that
hyperplasia was present in about a fifth of all
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cases and that an inactive endometrium comprised 
approximately three quarters of the total.
Secretory endometrium
The appearances in these specimens were 
essentially similar to those seen during the 
second half of the cycle during the reproductive 
period or life and do not necessitate detailed 
description. There were eight examples of this 
endometrial pattern in the cases of functional 
post-menopausal bleeding. In this group the time 
after the menopause was from one to six years and 
the ages of the patients ranged from-40 to 52 years. 
One patient, aged 42 years, had tad a menopausal 
dose of deep 2-ray therapy for abnormal uterine 
bleeding two years previously.
Hyperplasia of the endometrium was formerly 
considered to be a disease of reproductive life and 
it seemed reasonable to assume that some 
relationship might exist between the incidence of 
post-menopausal hyperplasia and the menstrual 
history of the patient. An analysis was therefore 
made of the type of endometrium found in these 
cases in relation to date at which menstruation 
ceased and the type of menopause experienced by
the patient. The results of this analysis are 
seen in Table 15.
Table 15
Age of menopause and endometrial pattern.
Tyne of Endometrium
Range of age 
at which 
menstruation 
ceased
Average
age
Atrophic Prom 21-59 years 47 #3 years
Inactive gland 
pattern " 35-54 " 45.1 "
Hyperplasia " 36-54 * 47# 3
Pibro adenomatous 
polyp " 3 d—54 " 47.0
Proliferative rt 41-63 rt 47 #2
The only 2 cases in which menstruation 
ceased before 35 years occurred in women who had 
had a bilateral oophorectomy performed on account 
of cysts of the ovaries. There was only one 
patient who menstruated regularily after the age 
of 55 years and she experienced the menopause at 
63 years. The endometrium obtained in the post­
menopausal period when she had some bleeding was 
of the proliferative pattern.
It will be seen from the table that there is 
no direct relationship between the type of 
endometrium found and the age at which the menopause 
occurred. Nor is there any significant difference
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in comparison with the age at which the menopause 
occurred in women who do not later suffer from 
post-menopausal "bleeding (See Table 2).
It might well he that these symptoms in the 
post-menopausal phase are merely a carry-over from 
a similar complaint during the reproductive phase.
If such were the case one might reasonably expect 
that a considerable number of patients would have 
had some form of treatment particularly the 
induction of an artificial menopause. The type of 
menopause experienced by the patients in relation 
to the endometrial pattern found in functional post— 
menopausal bleeding is shown in Table 16.
Table 16
Type.of menopause and endometrial pattern.
Type of Endometrium Natural
Artificial
Surgical
Peep
X-ray Radium
Atrophy b? 5 3 4
Cystic gland pattern 75 4 1 2
hyperplasia 106 3 — 1
Fibro adenomatous poly] 13 1 1 *
Proliferative 24 — 1 -
Secretory 7 1 —
While the numbers involved are small it would 
seem that an artificial menopause occurred relatively
oftener in cases showing atrophy or cystic gland 
pattern then in patients showing hyperplasia. When 
a comparison is made with normal post-menopausal 
women there is a higher incidence of an artificial 
menopause in those patients who suffer from 
"bleeding in the post-menopausal era (6 per cent, 
compared with 1.5 per cent.) hut this incidence is 
still relatively small and cannot be considered an 
important factor. It is obvious that in the 
majority of cases bleeding in the post-menopausal 
phase is a condition arising de novo. Not all 
patients who had an artificial menopause necessarily 
had hyperplasia of the endometrium at that time as 
it would seem that hyperplasia is present in only 
a third of cases of functional bleeding of the 
reproductive period of life.
In four cases where there was a history of 
excessive menstruation deisils of the curettage 
during the reproductive period were available. The 
first patient aged 42 was curetted because of 
profuse and irregular bleeding for two years. Only 
scanty curettings were obtained and were not sent 
for histological examination. A menopausal dose of 
deep X-ray to the ovary was given. When the
55*
patient was readmitted to hospital three years later 
because of bleeding of one month's duration active 
hyperplasia was found. Similar findings were 
noted in a second patient with the exception that 
the interval between the menopausal dose and 
subsequent bleeding was two years. In the other two 
patients bleeding at the time of the menopause was 
treated by curettage - the endometrium was noted to 
be thickened and on histological examination well 
marked cystic glandular hyperplasia diagnosed. Pour 
years and 11 years later respectively the patients 
suffered from post-menopausal bleeding and active 
hyperplasia of the endometrium was found when 
curettage was performed. It is apparent even from 
this small group of patients that the endometrial 
pattern found in the post menopausal phase bears 
little relationship to that existing during the 
reproductive years of life even when the patient has 
had a similar complaint in both periods.
In view of the possible effect of pregnancy 
on the hormonal balance of a woman and of p o s s i b l e  
endocrine imbalance in patients suffering from 
sterility an analysis was made of the marital 
status and parity of patients relative to the
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endometrial pattern present. The findings are 
shown in Table 17.
Table 17.
Parity in relation to endometrial pattern.
■ Type of endometrium Inmarried
Married
but
without
family Parous
atrophy 2 3 94
Oystic gland pattern 4 10 6 d
Hyperplasia 3 4 103
Fibro adenomatous poly ? 1 2 12
Proliferative 1 - 24
Secretory - - 8'
There is a larger number or unmarried and 
nulliparous women among the patients found to have 
an inactive gland pattern — a finding which is in 
close agreement with the figures obtained in the 
corresponding analysis for normal post-menopausal 
women. There does not however, appear to be any 
relationship between nulliparity and functional post­
menopausal bleeding. The majority of patients 
were parous and there was very little real 
difference between the various groups.
If endometrial hyperplasia is found shortly 
after the menopause it may be the persistance of 
a menopausal condition due to the recent endocrine
imbalance. It was found in the study of normal 
post-menopausal women that active hyperplasia of the 
endometrium was noted almost without exception 
within five years of the cessation of menstruation. 
It was therefore judged important to assess the 
incidence of the varying endometrial patterns in 
relation to the length of time after the menopause 
that it occurred in patients with bleeding. The 
findings are seen in Table lb.
Table lb
Time after menopause and endometrial pattern.
Years
after
the
menopause Atrophic
Cystic
gland
pattern
Hyper­
plasia
Pro-
lif-
erat-
ive
Pibro
adeno­
matous
polyp
Secre­
tory
Under 5 33.5 14. b 32.9 10.7 3.4 4.7
6-10 23.1 32.0 30. b 6.4 6.4 1.3
11-15 29.3 21.9 43.9 4.9 - -
16-20 26.-3 34.2 23.7 2. 6 13.1 -
Over 20 25.7 40 2b.6 5.7 - -
It is obvious from the above table that hyper­
plasia and proliferation of the endometrium are by 
no means confined to the early years after the 
menopause and indeed may be present over 20 ye ars 
after the cessation of menstruation. There were 
60 cases more than five years after the menopause 
as follows:- 6-10 years 23; 11-15 years 18;
3? -
16-20 years 3? and over 20 years 10. Thus active 
hyperplasia in the post-menopausal era associated with 
"bleeding is frequently found many years after the 
menopause. The findings become more striking when 
these figures are compared with those found in a 
study of normal post-menopausal patients.
Infection of the Endometrium.
The organisms most frequently responsible for 
endometritis are various strains of streptococci, 
often anaerobic, staphylococci and the tubercle 
bacillus. The chronic phases of inf lamination are 
far more frequently observed in the endometrium than 
the acute. In the senile variety the endometrium 
is frequently thin and atrophic and heavily 
infiltrated with round and plasma cells (Novak 1944). 
Ulceration of the surface may occur causing post­
menopausal bleeding. In cases of -tuberculous 
endometritis one may find only an occasional 
tubercle, or cluster of tubercles with the character­
istic epithelial and giant cells and where the disease 
is extensive caseation is present to greater or less 
degree.
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Pyogenic endometritis
Chronic pyogenic infection cf the endometrium 
was encountered 23 times where post-menopausal 
bleeding-had occurred from a grossly normal uterus 
representing 4.3 per cent. The infective process 
was not limited to endometrium of an atrophic type 
and its incidence in relation to the different 
endometrial patterns is shown in Table 19.
Table 19.
Infection in relation to endometrial pattern.
Type of 
Endometrium Atrophic
Inactive
gland
pattern
lyp er- 
Dlasia
Pro­
lifer­
ative
Pibro
adeno
polyp
Total No.of 
cases
No.of cases 
showing 
inf ection
99
8
82
8
110
5
25
1
15
1
It would appear from the above table that 
infection is relatively more frequent where the 
endometrium is either atrophic or inactive. 
Tuberculous infection
There were six cases of endometrial tuberculosis 
in post-menopausal women complaining of bleeding.
One patient five years after the menopause 
had a hysterectomy and bilateral salpingo 
oophorectomy performed. The endometrium was
Figure 9°
'U
M W
SPSS Sb  ss
sip
Cystic glandular hyperplasia in pa,tient suffering from bleeding
fifteen years after the menopause.
H & S x 75
Figure 10.
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thickened and filled the uterine cavity while the 
tubes were also thickened. Histological 
examination showed a cystic glandular hyperplasia 
associated with a definite tuberculous infection. 
Bilateral tuberculous salpingitis was also present. 
The appearances are illustrated in Pig.10.
In two cases there was a tuberculous infection 
of endometrium similar to that of the proliferative 
phase in the reproductive life.
There were two cases of a severe tuberculous 
infection of an atrophic endometrium.
The other patient suddenly developed a heavy 
white vaginal, discharge five weeks before admission 
and eight years after the menopause.
Vaginal bleeding followed examination in the out­
patient department. When the cervix was dilated 
large quantities of thick creamy pus poured from 
the uterus. A week later a catheter was inserted 
into the uterus and stitched in position to allow 
drainage of the pyometra. When curettage was 
eventually performed, tuberculous granulation 
tissue was obtained.
Discussion
There is an extensive literature on the subject
of post-menopausal bleeding though naturally 
much of it is concerned with the incidence of 
malignant conditions. Even where benign lesions 
are dealt with there is frequently little 
description of the histology of the endometrium 
and attention is focussed on obvious gynaecological 
lesions such as cervical polyp and decubitus 
ulceration of prolapse. More recently consideration 
has been given to the endometrial pattern and 
particularly hyperplasia of the endometrium. But 
many of the authors have not excluded such possible 
modifying circumstances as the presence of 
fibroids, granulosa cell or other tumour of the 
ovary or a history of the administration of 
oestrogen.
Benthin (1928) found endometrial polypi in 
24 per cent, of cases of post-menopausal bleeding 
due to benign conditions of the body of the 
uterus, but a description of the endometrial pattern 
is lacking, be considered that endometritis v/as 
an important factor in the other instances. The 
histological criteria for the diagnosis of 
"endometritis" are probably stricter at the 
present day and the diagnosis is less frequently
made. This observation is equally true of pre- 
and post-menopausal endometritis.
Schiffman (1929) likewise stressed the importance 
of endometrial polypi (11 out of 51 cases) but here 
again a histological description is lacking.
Fahmy (193 3) in an analysis of results 
obtained by several observers on the subject of 
post-menopausal bleeding-, grouped under the one 
heading such conditions as fibrosis uteri, ovarian 
dysfunction, metropathia/ haemorrhagica and 
endometrial hyperplasia. In many instances he 
recorded that the diagnosis was doubtful. Polyps 
are classified as benign tumours and no 
histological details are given. It is therefore 
impossible to assess the incidence of hyperplasia 
or other endometrial pattern in the cases he 
describes.
G-eist and Matus (1933) recorded 182 cases of 
post-menopausal bleeding which they had personally 
investigated. They found polyps in 29 cases but 
did not differentiate between fibro adenomatous 
and cervical adenomatous varieties. Hyperplasia 
was present in 10 of their cases (1 adenomatous 
polyp being included) but in 3 cases fibroids of 
the uterus were also present. In 13 patients they
could find no cause for the complaint.
Breipohl (1935) who included patients within 
6 months of the menopause found atrophy in 76 cases, 
hyperplasia in 13 and secretory endometrium in 3.
For the purposes of this calculation he considered 
non-productive curettage of the uterus to 
represent atrophy.
Taylor and hilien (1938) analysed 406 cases of 
post-menopausal bleeding and after elimination of 
those with an obvious pathological lesion were 
left with 34 patients in whom bleeding occurred from 
a grossly normal uterus. Of this number, prolapse 
was present in 9 and endometritis in 6. The varying 
patterns of the endometrium are detailed in the 19 
functional bleeding cases. Endometrial polyps were 
not considered as altered endometrial pattern but 
as benign growths.
Keene and Dunne (1938) in a series of 782 
cases of post-menopausal bleeding found hyperplasia 
of the endometrium 13 times out of 38 cases in 
which no organic cause of the bleeding was 
demonstrable.
Te Linde (1940) contented himself with the 
statement that endometrial polyps occasionally
occur and it is impossible to assess endometrial 
patterns in his cases.
Novak and Richardson (1941) made a histological 
study of the endometrium obtained frojn women in the 
post-menopausal period. They made a serious attempt 
to analyse the endometrial patterns found,and as 
far as possible ruled out cases where there was an 
obvious source of bleeding such as carcinoma of 
cervix or cervical polyp. They did not exclude 
cases where small fibroids were present as they 
did not consider the presence of these benign 
tumours would influence the type of endometrium.
The percentage incidence of the patterns of 
endometrium found by them was:-
Atrophy 49.1 per cent.
Proliferative 16.9 per cent.
Hyperplasia 20.4 per cent.
Retrogressive 13.6 per cent.
For the purposes of comparison with Breipohl1s 
figures it must be remembered that they ignored all 
cases where curettage did not produce sufficient 
endometrium for histological examination.
Geiger (1941) in an analysis of 395 cases of 
post-menopausal bleeding found 5 cases of endometrial
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hyperplasia, an incidence of 1.2 per cent.
Schwartz (1943) did not differentiate clearly 
"between hyperplasia and polypi, and a proportion cf 
his cases had fibroids of the uterus present. 
Moreover it is doubtful if all the patients in 
his series had in fact had a complete cessation of 
menstruation. This probably accounts for the high 
incidence of secretory endometrium.
Cheek and Davis (1946) analysed 514 cases of 
post-menopausal bleeding. Details of the endometrial 
pattern are given in 3b cases where the bleeding 
could be termed functional? hyperplasia in 20 and 
polypi in lb. But the hyperplastic group 
included some examples of polypi, and there is 
therefore some uncertainty of the criteria of 
both polypi and hyperplasia. In six cases of their 
series endometritis was present.
Kottmeier (1947) described 14b cases of post­
menopausal bleeding in which the endometrium 
showed signs of response to hormonal stimulation.
In 30 cases they found an associated ovarian 
tumour and in 31 there was a history of the 
administration of oestrogen. Of the remaining b7 
patients, 28 had bleeding within two years of the
6 6.
menopause. They found an elevated urinary excretion 
of oestrogen in 65 patients and in 53 of these 
laparotomy was performed. A granulosa cell tumour 
was present 42 times. Of yo patients with post­
menopausal bleeding due to a uterine polyp in only two 
did' an ovarian tumour develop.
Lund and Dougherty (1949) in a communication 
dealing with benign post-menopausal bleeding 
described the finding of active and "retrogressive" 
hyperplasia. They considered that the latter 
condition did not signify co-existing oestrogenic 
stimulation. Indeed they suggested that patients 
probably did not bleed from this condition and its 
finding was probably incidental.
Jones and Cantor (1951) dealt with functional 
bleeding of the post-menopausal epoch and 
distinguished between hyperplasia and polypi.
They found endometrial polypi in 4 per cent, and 
hyperplasia in 3.6 per cent, of all cases. In 
discussing, polypi they recorded their occurrence in 
uteri removed for other pathology.
It will be seen from this survey of the 
literature that it is difficult in the first instance 
to distinguish cases with organic lesions of the
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genital tract from cases of functional post­
menopausal bleeding. Moreover endometrial polyps 
are frequently mentioned but histological 
descriptions are lacking in most instances. With 
these reservations it is calculated that hyperplasia 
occurred 113 times in a total of 409 cases of 
functional post-menopausal bleeding. This represents 
an incidence of 2b per cent. Atrophy of the 
endometrium probably occurs in slightly over 5 5 per 
cent, of cases. Proliferative endometrium is 
mentioned only by a few authors but when it is 
assessed, it occurs in about lb per cent, of the 
total of functional post-menopausal bleeding cases. 
Polypi and secretory endometrium make up the 
remainder but it is impossible to calculate the 
incidence with any degree of accuracy.
The incidence of active hyperplasia in 
functional post-menopausal bleeding in the present 
series is 20.5 per cent, compared with 1.7 per 
cent, in normal post-menopausal women. Moreover, 
proliferative endometrium represented 4.6 per cent, 
compared with 0.b per cent, in the non-bleeding 
cases. Secretory endometrium which did not occur 
normally in post-menopausal women was found in
<se.
1.5 percent, of cases of functional bleeding after 
the menopause. Thus in 26.6 per cent, of all cases 
of functional post-menopausal bleeding the 
endometrium showed histological evidence of activity. 
In 73*4 per cent, of these cases an inactive 
endometrium was present although a considerable 
proportion showed polypi or a diffuse cystic gland 
pattern*
In normal cases when hyperplasia was noted 
it occurred in the early years after the menopause. 
This suggests that it was in some way related to 
the endocrine imbalance known to be present around 
that period, and it is possible that in these 
cases the patient was still under the influence of 
the menopausal changes. Hyperplasia associated 
with bleeding, however, showed no particular age 
incidence in relation to the menopause. It was 
found from 1 to 34 years after the menopause and 
showed a fairly even distribution throughout the 
five-year age groups. It would appear therefore 
that hyperplasia in these circumstances is not a 
mere continuation of the changes which may be 
found at the menopausal period but is a new 
pathological entity.
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Investigation of the menstrual history of 
these patients showed that there was no 
relationship between the occurrence of functional 
post-menopausal bleeding and any menstrual 
disturbance of the reproductive era. In addition 
in the few patients who had suffered from excessive 
bleeding before the menopause and who later 
complained of post-menopausal bleeding no correlation 
could be found between the endometrial patterns 
on these two occasions. For instance, hyperplasia 
associated with bleeding during the reproductive 
period was followed in 2 cases, 2 and 4 years after 
the menopause respectively by haemorrhage from an 
inactive gland pattern of the endometrium.
With the pronounced endocrine changes 
associated with pregnancy it might reasonably be 
expected that repeated pregnancies would have some 
influence on the character of the endometrium. It 
did not appear, however, that regeneration of the 
endometrium following labour or abortion 
influenced in any way the onset of bleeding or 
altered the endometrial pattern in these post­
menopausal cases.
The striking feature of this group of cases
is the high incidence of hyperplasia and its 
occurrence many years after the menopause. This 
high incidence of hyperplasia is not unexpected 
since in the absence of demonstrble pathology, 
one would tend to assume that the symptoms are the 
result of endocrine influence. Although a number 
of factors may be responsible for maintaining the 
integrity of the endometrium the experimental work of 
Geist'.and Salmon( 1941)would suggest that hyperplasia 
of the endometrium is particularly associated with 
oestrogen activity. This would provide a 
satisfactory explanation for the occurrence of 
hyperplasia in these cases of post-menopausal 
bleeding, and is supported by the occasional 
occurrence of a secretory endometrium, which was 
noted in S instances. Breophol reported 3 similar 
cases in a series of 130 patients with post­
menopausal bleeding. Taylor and Millen also found 
a secretory pattern once in 34 cases of bleeding 
from a grossly normal uterus. Some objection may 
be raised to these reports since the authors state 
that in every instance the discovery was made 
within a year of the cessation of menstruation. In 
the present series a secretory pattern was found
from one to six years after the menopause.
Secretory activity in the endometrium during 
the reproductive life occurs under the influence 
of progesterone. It has been shown however that 
progesterone by itself is incapable of inducing 
such change unless the endometrium has been 
sensitised by oestrogen. It has, however, been 
suggested that a secretory endometrium may also 
result from the action of oestrogen and androgen 
the latter hormone being secreted by the theca 
cells of the ovary (Shippel, 1950). The occurrence 
of these-cases thus strengthens the conception 
that post—menopausal bleeding is associated with 
some degree of oestrogen activity.
It must be remembered, however, that in more 
than 70 per cent, of the cases the endometrium was 
atrophic. This does not accord with the usual 
views relating to the effects of oestrogen activity 
on the endometrium. Two possible explanations 
arise for consideration. It may be that in these 
cases showing atrophy of the endometrium some 
agent other than oestrogen exists and is responsible 
for the bleeding. Alternatively it is conceivable 
that hyperplasia of the endometrium does not 
invariably follow upon oestrogenic stimulation.
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For this reason it was decided to make a study of 
post-menopausal patients in whom an excess of 
oestrogen was presumed to he acting as in cases 
of granulosa cell tumours of the ovary. In 
addition patients known to he having oestrogen 
administered therapeutically were investigated 
with particular reference to the endometrial 
findings.
Group £
Over a period of twelve years eleven cases of 
granulosa cell tumour of the ovary have heen found 
in post-menopausal patients in the Royal Samaritan 
Hospital for Women, Glasgow. A voluminous literature 
has accumulated relating to the condition. Novak 
and BraMner (1934); Bland and Goldstein (1935);
Meigs (1935); Novak and Gray (1936); Pratt (1937); 
Chaney and Greenhlatt (1933); Yarangot (l93o); 
Dockerty and MacCarty (1939); Dockerty and 
-pounseller (1940); Karsner (1940); Traixt and Marchetti 
(1940); Novak (1941); Henderson (1942); Novak (1942); 
Kottmeier (1944); Novak (1944); Hodgson, Dockerty 
and Massey 0-945); Rhoads (1946); Dockerty (1947); 
Falls, Eagins and Goldherg (1949); Haines and 
Jackson (1950); Corscaden (1951); Diddle (1952).
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There seems to he no doubt that these tumours 
secrete oestrogens as demonstrated by biological 
tests, (Frank, 1932; Gospe, 1936; and Palmer, 1939). 
For this reason these cases provide a control 
series whereby we may assess our findings in other 
groups* In view of the importance of this group, 
details of clinical history will be given for most 
of the cases*
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CASE HISTORIES 
Four of the cases had a typical history 
associated with a pelvic tumour and it was possible 
to make a presumptive diagnosis prior to operation, 
in two of them.
1. The first case was of an unmarried patient 
aged 67 who, 15 years after the menopause, began 
to have profuse vaginal bleeding. Five days alter 
its onset she was admitted to hospital and 
curettage was performed. Examination at the time 
of the operation revealed the presence of a pelvic 
tumour. Histological examination of the endometrium 
showed active glandular hyperplasia. Laparotomy 
was performed a few days later and an inoperable 
ovarian tumour was found. Microscopical 
examination of a specimen showed it to be of the 
granulosa cell type.
2. A married patient aged 54 was admitted because 
of vaginal bleeding of 3 months duration occurring 
4 years after the natural menopause. An ovarian 
cyst, the size of a melon, was discovered on 
abdominal examination. Hysterectomy and bilateral 
salpingo oophorectomy was performed. Naked eye 
examination showed a thickened endometrium.
Histological examination showed that the tumour was 
a granulosa cell carcinoma of the diffuse or 
parenchymatous variety and there was hyperplasia not 
only of the endometrium hut also of the epithelium 
of the Fallopian Tube.
3. A woman aged 5b and tf years after the menopause 
was admitted with a history of bleeding for three 
months. Curettage revealed a thickened endometrium 
which on microscopical examination was seen to be 
hyperplastic. At the time of operation an ovarian 
tumour the size of a tangerine was palpated on the 
right side of the pelvis. The association of these 
two findings led to a presumptive diagnosis of 
granulosa cell tumour. The diagnosis was confirmed 
when the ovarian tumour was subsequently removed.
4. A granulosa cell tumour was removed from a 
patient who had complained of post-menopausal 
bleeding. The uterus was not removed and there 
was no opportunity to examine the endometrium.
In the following four cases the true diagnosis 
was unsuspected initially and it was only when the 
symptoms recurred, in three cases after the patients 
had received a '’menopausal dose" of X-rays that the 
presence of a granulosa cell tumour was considered.
5* A married woman of 59 was admitted to hospital 
because of four severe haemorrhages which had 
occurred in the previous 10 years. The patient had 
ceased to menstruate at the age of 40. Curettage 
revealed the presence of active hyperplasia of the 
endometrium and a "menopausal dose" of deep X-ray 
was given. Six months later because of bleeding of 
a fortnight's duration hysterectomy and bilateral 
salpingo oophorectomy was performed. The ovary 
contained a granulosa cell tumour and active hyper­
plasia of the endometrium was present.
6. A married woman 14 years after a natural 
menopause complained of bleeding of six months duration. 
Curettage produced bulky curettings which showed 
active hyperplasia. Three and a half years later 
there was a recurrence of bleeding and a further 
curettage was performed. Again the endometrium 
was thickened and on histological examination showed 
active hyperplasia. A small granulosa cell tumour 
of the ovary was found on laparotomy.
The true nature of the condition was not 
appreciated at the time hysterectomy was performed 
and it was only after histological examination that 
a diagnosis could be made in two cases.
7. A married patient of 56 complained of 
irregular bleeding for the previous 6 months.
Bulky endometrium showing active hyperplasia was 
obtained on curettage, A "menopausal dose" of 
deep X-ray was given. There were recurrences of 
bleeding thereafter and one year later curettage 
was repeated. The cervix and vagina were noted to 
have the appearances seen in women of the reproductive 
phase of life and mucus was being secreted by the 
cervix. The endometrium was hyperplastic and it
was considered advisable to perform a laparotomy.
The ovaries were not noticeably enlarged but 
histological examination showed islands of granulosa 
cell tumour.
8. A nulliparous patient aged 60 was admitted to 
hospital because of vaginal bleeding occurring 8 
years after the menopause. Curettage was performed 
and the endometrium showed cystic glandular hyper­
plasia of such a degree that it was reported as 
being obviously under the influence of oestrogen.
There was, however, no history of the administration 
of oestrogen. Two years later the patient was 
readmitted to hospital having had bleeding 
comparable to a menstrual period at intervals from one to
four months. Curettage was again performed and 
"bulky curettings obtained. Again the endometrium 
showed such active hyperplasia that it was suggested 
that it was being acted on by oestrogens. 
Hysterectomy and bilateral salpingo oophorectomy 
was performed but even at operation an abnormality 
of the ovary was not obvious. At pathological 
examination the left ovary was seen to be atrophic. 
The right ovary measured x -J-" and when it was 
bisected it was seen to contain a white tumour less 
than half an inch in diameter. Histological 
examination showed it to be of the granulosa cell 
"type.
9* Case 9 is interesting in that the initial 
complaint of bleeding 20 years after the menopause 
did not recur after curettage. The patient aged 70 
and was 20 years after the menopause when bleeding 
occurred. Post-menopausal hyperplasia of the 
endometrium was discovered. Six years later she was 
admitted to another hospital because of abdominal 
pain. At laparotomy an ovarian cyst which had 
undergone torsion was discovered. Histological 
examination showed it to be of the granulosa cell 
type and the endometrium showed active hyperplasia.
The following- two cases are of importance 
because they provide material for discussion 
when considering the relationship of endometrial 
pattern to the occurrence of bleeding.
10. A married patient aged 59 and 19 years after 
the menopause was admitted because of four severe 
haemorrhages in the previous 10 years. Curettage 
revealed an inactive cystic glandular pattern of 
the endometrium. Deep X-ray therapy to the ovaries 
was given but six months later the patient was 
readmitted because of a recurrence of bleeding. 
Hysterectomy was performed. The endometrium lining, 
the uterus showed an inactive cystic gland pattern 
and the ovary contained a granulosa cell tumour.
11. An unmarried patient aged 56 and 16 years after 
the menopause was admitted because of abdominal pain. 
There was no history of bleeding and a granulosa 
cell tumour of the ovary was found. The endometrium 
showed an inactive gland pattern.
It will be seen from the above that eight of 
these followed the usual clinical course of this 
condition. They are of considerable interest to 
the clinician in that it was possible to make the 
diagnosis of granulosa cell tumour even in the
absence of a palpable pelvic mass. This can be 
observed in cases 4, 5, 6 and 7. It would appear 
that bleeding with hyperplasia recurring after 
curettage in the post-menopausal patient and in the 
absence of any local pathological condition is 
probably due to granulosa cell tumour.
A "menopausal dose" of deep X-ray is frequently 
employed in the treatment of menopausal haemorrhagia 
and it would seem to result in cessation of ovarian 
function with subsequent cure of the abnormal 
bleeding. When the hyperplasia and bleeding occur 
in the post-menopausal epoch and are due to a 
granulosa cell tumour of the ovary, the bleeding 
shows a tendency to recur. This suggests that the 
ovarian tumour cells may have their function 
temporarily destroyed by the X-rays. The cells 
eventually recover their vitality and apparently 
the endocrine function is unimpaired. This is 
deduced from the recurrence of hyperplasia and 
bleeding in such cases.
It is noteworthy that in one case (No. 9) 
curettage resulted in cessation of bleeding but 
hyperplasia persisted or recurred. Prom a study 
of normal post-menopausal women it is obvious that
hyperplasia may exist independently of the 
occurrence of bleeding and this case emphasises 
that finding. While there may be some inter­
relationship it is not necessarily direct. This is 
also suggested by the findings in Case 10 in which 
bleeding was twice noted in association with an 
inactive gland pattern.
The finding of an inactive gland pattern 
without bleeding in association with a granulosa 
cell tumour is difficult to interpret. It may be 
that the tumour in this case had 110 functional 
activity in relation to endocrine production.
There are many references in the literature 
of the past 25 years to the occurrence of granulosa 
cell tumours and particular stress ha^been laid on 
the occurrence of hyperplasia of the endometrium 
in such cases. Novak and Brawner (1934) in a study 
of granulosa cell tumours found that of the six 
occurring in the post-menopausal age there was 
coincident hyperplasia of the endometrium in five. 
Henderson (1942) found hyperplasia of the endometrium 
(in one case associated with a polypus) in every 
post-menopausal case. Haines and Jackson (1950) 
reported on a series of granulosa cell tumours
including 19 cases occurring after the menopause.
Only two thirds of the number actually suffered 
from post-menopausal bleeding. In the others the 
complaint was of pain in or swelling of the abdomen.
The endometrial pattern was only noted in nine cases 
and in seven instances it was of the drongiy 
oestrogenic type. They also refer to the finding 
of an endometrial polyp and in at least one case 
no endometrium was obtained at curettage. Spencer 
and Hollenbeck (1947) also reioort the presence of 
hyperplasia in two cases out of three. There was 
no bleeding in the other example. In a number of 
other cases the instance of hyperplasia is less 
convincing. Rhoads (1946) refers to the finding 
of mild physiological hyperplasia of the endometrium 
in association with a granulosa cell tumour of the ovary. 
Brewer and Jones(I93.3).ih describing three cases 
obviously consider endometrial polypi as 
manifestations of hyperplasia.They describe 
polyp with spare narrow tubular glands and a dense 
stroma. Bianco and Favorite (1946) make the 
somewhat vague statement that in the case of 
granulosa cell tumour reported by them the 
endometrial picture was compatible with that
described by others in a similar condition.
Stohr (1942) found uterine bleeding with or 
without hyperplasia of the endometrium was present 
in 71.7 per cent, of cases of granulosa cell tumour 
of the ovary. In 2b. 3 per (cent, there was failure 
to produce hyperplasia or bleeding but of these 
cases only two had occurred after the menopause.
Finally Diddle (1952) collected and analysed 
as many as possible of the recorded case reports of 
patients with granulosa cell tumours. Data 
concerning the endometrium was available in two 
thirds of all cases. There were 415 instances of 
hyperplasia as opposed to 25 of atrophic change. 
Endometrial polyps were seen more commonly in 
women with endometrial hyperplasia that in those 
without.
Interpretation
While there may be an occasional case in which 
the tumour is functionally inactive, the great 
majority of granulosa cell tumours do have an 
endocrine effect and it has been proved by Frank, 
Gospe and Palmer that they do produce oestrogen. 
Cases 9 and 10 are the most significant in 
relationship to this thesis in that bleeding and
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hyperplasia are shown to he separate entities in 
these cases. Hyperplasia may occur in the absence 
of bleeding. This may well be related to 
particular oestrogen blood levels. At the same time 
it is even more interesting to note that bleeding 
may occur in the absence of hyperplasia. That 
bleeding per se in these cases is due to the action 
of the tumours is shown in Case 12 where removal 
of the tumour alone resulted in cessation of 
bleeding.
Experimental evidence is always more 
convincing than an uncontrolled natural phenomenon 
even when the changes are as striking as those 
presented by the above cases. It was therefore 
thought that valuable evidence might be obtained 
from a study of material obtained following the 
administration of oestrogens to patients. Before 
proceeding to this, however, the following case may 
prove of interest in that it provides further 
evidence, albeit indirect, for the presence of 
oestrogen activity in post-menopausal bleeding.
An unmarried nulliparous patient aged 6b 
years and 16 years past the menopause was admitted 
with a history of vaginal bleeding of a fortnights 
duration. Curettage was performed find active
hyperplasia of the endometrium was diagnosed. A
week later hysterectomy was performed. The left
ovary was enlarged to four times its normal size
and contained a smallthecoma.
Bleeding in patients who have been receiving 
oestrogen therapy.
A number of writers have discussed the relation­
ship between post-menopausal bleeding and oestrogen 
therapy and have condemned the indiscriminate use 
of oestrogens in post-menopausal patients, Novak 
(1944-a); Cheek and Davis (1945); Noyes (1945);
Feeney (1947); and Eanter and iOawans (1950).
A history of administration of oestrogens 
either orally in the form of stilboestrol or by 
inunction of an ointment containing oestrogen was 
obtained in 29 cases of post-menopausal bleeding - 
an incidence of 1.4 per cent. It is probable that 
this figure errs on the low side as occasionally 
a patient may be having oestrogen therapy from her 
practitioner without being aware of the fact and 
without the practitioner making it known to the 
consultant. The commonest indications for the 
giving of oestrogen were kraurosis or the 
troublesome symptom of 'hot flushes'. But in a
proportion of cases the rationale was not clear, 
no gynaecoloL ;ical symptom being present. The 
patients' ages varied from 46 to 74 years and they 
were from 4 to 23 years past the menopause.
Even where a clear cut history is obtained that 
a patient suffering from post-menopausal bleeding 
has been receiving' oestrogen, curettage is frequently 
performed to exclude a possible co-existing 
malignant condition. This precaution was taken 
in all the cases in this group in the present series, 
no endometrium being obtained in eight cases.
Active hyperplasia of the endometrium was 
discovered eight times, atrophy six times, an 
inactive dilated gland pattern five times and 
proliferation of the endometrium twice. The incidence 
of an active endometrial pattern was therefore 34.5 
per cent, in patients known to have received 
oestrogens prior to curettage.
It was not possible accurately to determine 
in all cases the amount of oestrogen administered 
nor the duration of the treatment, and I have not 
been able to correlate these factors with the 
endometrial pattern present. Two cases however, 
by reason of the contrast they provide, are worthy
of note. There was one instance of an extreme 
degree of active hyperplasia of the endometrium 
following the use of an ointment containing only a 
very small/amount of oestrogen over a period of several 
weeks. By comparison, no endometrium was obtained on 
curettage from the uterus of a patient who had been 
taking stilboestrol daily over a period of two 
years.
The ability of oestrogen to produce hyperplasia 
of the post-menopausal endometrium is well 
established (Taylor 1932) and bleeding from the 
uterus after the administration of oestrogen is a 
clinical entity sufficiently common to have 
been termed "oestrogen-withdrawal" bleeding. The 
incidence of a history of the administration of: oestrogen i 
cases of post-menopausal bleeding is variously 
reported at 2.3 per cent. (Cheek and Davis, 1946) |
to 4.5 per cent. (Jones and Cantor, 1951).
•' I
It has been considered that oestrogen produces 
hyperplasia of the endometrium and when the hormone 
is withdrawn, degeneration of the endometrium 
occurs with subsequent bleeding. Novak (1944—a) 
while not giving figures, states that the prevailing 
endometrial pattern in such cases is active hyper- ' j
plasia. But he also describes cases in which a 
typical picture of "retrogressive hyperplasia", i.e. 
an inactive dilated gland pattern was seen.
Cheek and Davis (1945) recorded that in most 
of their cases relatively little endometrium was 
obtained, active hyperplasia being present in only 
two out of twelve instances. Geist and Salmon 
(1941) found a histological pattern of proliferation 
with distended glands, the endometrium later 
showing a quiescent state.
Thus it would seem that a known factor, i.e. 
oestrogen is involved and that bleeding in post­
menopausal women follows the administration of 
this hormone. And as has been shown, there is a 
high incidence of active hyperplasia of the 
endometrium in these cases. But it is surprising 
to find bleeding without an endometrial pattern 
usually taken to indicate oestrogen activity. In 
considering the effect of endocrine action on any 
tissue the reactivity of the end organ concerned 
must be taken into account. Further evidence of the 
importance of this factor is afforded by the 
exceptional occurrence of hyperplasia of the breast 
tissue in elderly women following the administration
of oestrogen.
Summary
1. The pathological findings in 2056 cases of post­
menopausal bleeding were analysed.
2. Eleven cases of granulosa cell tumour of the 
ovary and one thecoma were described.
3. Malignant conditions of the genital tract were 
responsible for the bleeding in 27.6 per cent.of 
the total cases.
4. In cases where a benign extra-uterine source of 
bleeding v/as present there was no significant 
variation in the incidence of endometrial 
patterns compared with the normal.
5* An increased incidence of hyperplasia was noted 
in cases of fibroids of the uterus.
6. Functional post-menopausal bleeding accounted 
for26,1 per cent, of the total cases.
7. The incidence of hyperplasia in functional post­
menopausal bleeding was 20.5 per cent.
8. Active hyperplasia associated with bleeding was 
not restricted to the early post-menopausal 
years, but typical examples occurred as late
as 30 years after the cessation of menstruation.
90.
9. Secretory endometrium was found in 1.5 per cent, 
of cases.
10. Infection of the endometrium occurred in 4.3 per 
cent, of cases of "functional" postmenopausal 
bleeding. Infection, both pyogenic and tuberculous,:
7 i
occurred not only in association with an inactive ! 
endometrium, but was found in cases of active 
endometrial hyperplasia.
11. Investigation of patients receiving oestrogen 
therapy revealed that bleeding due to this 
substance was not always associated with 
endometrial hyperplasia, only 34.5 per cent, 
showing an active endometrial pattern. h
SECTION 3
SIGNIFICANCE OF SENILE ENDOMETRIAL POLYPI
There is frequent reference in the literature 
to the occurrence of endometrial polypi in normal 
post-menopausal women, in patients suffering from 
bleeding after the menopause and in association 
with endometrial carcinoma. Novak (1941) and 
Speert (1949) report this finding in normal post­
menopausal women. The finding of such polyps in 
post-menopausal patients with bleeding is noted by 
Fahmy (1933), Te Linde (1940), Schwartz (1943) 
and Jones and Cantor (1951), and the association 
of endometrial polyps and carcinoma is referred to 
by Beattie (1933) 9 and Hertig and Sommers (1949).
The term polyp is a clinical rather than a 
pathological one, referring simply to a growth 
which is attached by a pedicle, and not indicating 
in any way its histological characters. The 
endometrial polyp consists of a localised heaping 
up of that tissue. These polyps may be single or 
multiple, small or large enough to fill the uterine 
cavity. The pedicle may be short or so long that 
the body of the polyp protrudes the cervix.
During the reproductive life polyps may he 
functional and correspond to the general endometrial 
pattern. This is exemplified in cases of cystic 
glandular hyperplasia of the reproductive years 
where the whole of the endometrium lining the 
uterus is thickened and in areas it is polypoidal.
In the post-menopausal woman, however, the polyp 
seems to hear little relationship to the 
endometrium lining the rest of the uterine cavity.
The polyp is frequently solitary, composed of an 
inactive dilated gland pattern, and found in 
association with a thin or inactive endometrium.
The essential difference between the two conditions 
is that whereas in hyperplasia the polyp is an 
integral part of a generally hyperplastic endometrium, 
in the post-menopausal era the polyp is the sole 
thickened portion of the endometrium lining the 
cavity.
It is obvious from a survey of the literature 
that there is considerable difference of opinion 
concerning the significance of these polyps and 
the mode of their development. In general their 
presence has been interpreted in four different 
ways.
Cheek and Davis (1946), Taylor (1932) and 
Schwartz (1943) although listing endometrial 
polypi and hyperplasia separately in their causes 
of post-menopausal bleeding nevertheless refer to 
the frequent finding of polypi associated with 
hyperplasia. This suggests a common aetiological 
factor and Taylor refers to the already recognised 
relationship which exists between the two 
conditions.
Novak and Richardson (1941) gave the name 
"retrogressive hyperplasia" to the inactive cystic 
gland pattern which is present in these polypi. 
They considered that these polypi occurred in 
patients whose terminal menstrual cycles had been 
anovulatory, the endometrium showing cystic 
glandular hyperplasia. In the post-menopausal 
years a process of mummification takes place and 
the inactive cystic gland pattern develops. Thus 
according to both these views endometrial polyps 
with cystic dilated glands are related to 
endometrial hyperplasia. In the one case the 
hyperplasia is thought to be co-existent and in 
the other preceding - often by many years - the 
formation of the endometrial polypi.
Other observors have not related the production 
of an endometrial polyp with hyperplasia, past 
or present. Fahmy (1933) and Taylor and Millen 
(193b) regard polypi of this nature as benign 
tumours. Lund and Dougherty (1949) refer to the 
confusion between hyperplasia and polyps. In 
their opinion, polyps are not related to generalised 
hyperplasia but the superficial histological 
similarity of the gland pattern may be responsible 
for an erroneous diagnosis of hyperplasia.
Speert (1949) considers that the dilated glands of 
which these polypi are composed represent simple 
retention cysts, and the polyps themselves are 
merely a localised aggregation of such distended 
glands.
In the preceding sections of the thesis these 
polypi have been placed in a separate group, but 
in view of the suggested relationship between 
polypi and hyperplasia it is necessary to compare 
the incidence of the two conditions in the post­
menopausal woman - with and without bleeding. In 
the following only polypi of an inactive type 
as described in the first section of the thesis are 
considered.
Patients Without Bleeding
Total number of cases 1520
Cases of polypi BO representing 5.2
per cent.
Cases of hyperplasia 26 representing 1.7
per cent.
These figures represent the findings on 
curettage and in the section of the thesis dealing 
with the normal post-menopausal endometrium 
arguments were adduced whicSuggested that the real 
incidence of polypi was considerably higher. When 
the entire uterus was available for study the 
incidence of polypi was 15 per cent. If the former 
figure is utilised the ratio between endometrial 
polypi is 3 to 1, or, if the more accurate figure 
is accepted the ratio becomes 8 to 1.
Patients With Bleeding
In cases of functional post-menopausal 
bleeding the incidence of endometrial polypi and 
hyperplasia is as follows
Total number of cases 537
Cases of polypi 76 representing 14.1
per cent.
Cases of hyperplasia 110 representing 20.5
per cent.
The ratio between endometrial polypi and
hyperplasia is now reversed, being 2 to 3. If we 
accept the higher figure of 15 per cent, as the 
incidence of polypi in normal post-menopausal 
women, we find in the patients with bleeding that 
this is not materially altered from the normal 
figure.
This great diminution in the ratio of polypi 
to hyperplasia of the endometrium scarcely suggests 
that these focal lesions are examples of 
hyperplasia. It may be, however, that these 
polypi represent an example of previous hyper­
plasia which has undergone retrogression and 
one would naturally expect this feature to be 
related to a time factor. If this is so it ought 
to be apparent in an analysis of age groups. In 
the following table the total number of cases in 
all groups, normal and pathological, have been 
assessed according to the incidence of polypi 
and endometrial hyperplasia in the various post­
menopausal age groups.
At first sight it may appear from Table 2Q; 
that there is an inverse relationship between 
hyperplasia and polypi but if the "under 5 year" 
group are omitted it will be seen that the
incidence of polypi does not alter significantly.
The low incidence of polypi in the first stage group 
is entirely fallacious and is due to the marked 
variation in endometrial pattern at this time. It 
would appear from the figures that there is no 
statistical evidence to suggest that endometrial 
polypi are directly related to hyperplasia.
Table 20.
Time after menopause in relation to hyperplasia and 
endometrial polypi.
Years after 
the 
Menopause Hyperplasia Polypi
6 - 1 0 31.3 18.9
11 - 15 24 42.3
16 - 20 16.4 49.8
Over 20 years lb. 0 50.3
A study of the histology of these endometrial 
polypi gives a general impression of inactivity of 
the tissues. The epithelium lining the glands is 
flattened and mitotic figures are absent. The 
stroma is less cellular than endometrial stroma 
usually is and mitotic figures which are so 
prominent in active hyperplasia are rarely present. 
Indeed the resemblance to hyperplasia is entirely 
based on the disparity in the size of the glands,
and it is noteworthy that the glands of polyps 
frequently attain a size much larger than is ever 
seen in active hyperplasia. This does not accord 
with the findings of Taylor, who in a study of 
50 endometrial polyps found associated generalised 
mucosal hyperplasia in one third of 18 polyps.
In addition, in 33 he found gland patterns 
essentially similar to that found in diffuse disease 
and which exhibited the same variations in degree 
of hyperplasia. Lund and Dougherty (1949), 
however, referred to the confusion between 
endometrial hyperplasia and polyps. They considered 
that polyps grew because of a local stimulation 
as distinguished from hyperplasia which had a more 
uniform generalised activity. Kottmeier (1947) 
described 148 cases of post-menopausal bleeding in 
which there was hyperplasia of the endometrium.
In the majority of his cases there was either a 
history of administration of oestrogen (31 cases) 
or a granulosa or theca-cell tumour of the 
ovary was present (72 cases). By contrast, in 
90 cases of bleeding due to an endometrial polyp 
in only i m did an ovarian tumour develop. Thus 
neither Lund and Dougherty nor Kottmeier were of
the opinion that a polyp of inactive cystic gland 
pattern signified co-existing oestrogen stimulation.
In view of the suggestion that this gland 
pattern designated "retrogressive hyperplasia" 
by Novak is related to hyperplasia occurring at the 
time of the menopause a study of the age at 
menopause and type of menopause experienced was 
made. The average age at menopause was 47.8 years - 
a figure which is in close agreement with the 
average age in all the endometrial patterns studied. 
Patients in whom polypi occur do not have a later 
menopause then patients who later show endometrial 
atrophy.
There were 156 patients in whom endometrial 
polyp was noted. ^n 147 instances the menopause 
occurred naturally without excessive bleeding at 
that time. There were 3 cases where a menopausal 
dose of X-ray was given because of menopausal 
menorrhagia and twice radium was given for similar 
indications. There were 3 patients in whom the . 
menopause follov/ed bilateral oophorectomy under­
taken because of benign ovarian cysts or salpingo 
oophoritis. Thus in only 5 cases out of 156 
was there menopausal menorrhagia and in one of
these cystic glandular hyperplasia was present.
Cystic glandular hyperplasia was also noted at 
curettage a year before the menopause in one 
instance. The periods subsequently were normal and 
X-ray treatment was not given.
The first patient at the age of 49 had 
suffered from irregular bleeding for six months. 
Curettage was performed and cystic glandular 
hyperplasia of the endometrium was diagnosed. There­
after the periods were normal for 2 years at which 
time they stopped. After lb months amenorrhoea 
she had further bleeding for a fortnight and was 
admitted to hospital for investigation. At 
operation she was found to have a senile vaginitis 
and on curettage an endometrial polyp was removed.
On microscopical examination it was seen to be of 
the inactive type, with greatly distended glands.
The second patient also aged 49 had had 
prolonged and irregular periods for a year before 
her first admission to hospital. Curettage produced 
thickened endometrium showing the typical changes 
associated with metropathia haemorrhagica. A 
menopausal dose of deep X-ray was given, but the 
patient had further bleeding four months later.
Additional deep X-ray therapy was given. There 
was no further bleeding until four and a half years 
later. Although preliminary curettage revealed 
scanty endometrium hysterectomy was performed.
When the uterus was opened an endometrial polyp, 
necrotic at the tip was discovered at the fundus.
On histological examination it was seen to have 
distended glands lined by flattened epithelium 
and it was quite inactive in appearance.
These two cases represent the finding of a 
post-menopausal endometrial polyp in patients who 
were known to have had menopausal hyperplasia.
But the fact that this sequence was only noted 
twice in 156 cases suggests that this is not in 
fact the normal mode of development of endometrial 
polyps.
Thus the diffuse gland pattern occurs 
normally in 20 per cent, of post-menopausal women 
and polyp formation of similar appearance was 
noted in an additional 15 per cent. If such 
patterns were to be considered the aftermath of 
hyperplasia at the time of the menopause as 
suggested by Novak and Yui the inference would be 
that such a condition was present in more than one
third of all women of this age. This does not 
seem likely from a clinical history of the patients 
with polypi and Sharman's (1953) findings suggest 
that ovulatory cycles rather than hyperplasia are 
the normal findings in the terminal menstrual 
cycle of women.
Indeed as has been stated the appearance of 
the histology of the polyps is one of inactivity. 
The epithelium of the glands is flattened and 
inactive differing from the atrophic pattern only 
in the flattening of the cells due to distension 
of the glands. The stromal cells likewise show 
lack of mitotic activity and are similar in 
appearance to those found in atrophic endometrium. 
In other words the only difference between an 
atrophic endometrium and the diffuse cystic 
glandular pattern is the presence in the latter 
of distended glands. These may well be simply 
retention cysts and in Speert's view they result 
from the occlusion of the gland openings which 
is caused by atrophy and contraction of the lining 
epithelium. Such an explanation is in accord with 
the frequency of occurrence of the dilated gland 
pattern which would imply a cause operative in
more than one third of cases. It is also 
compatible with the inactive appearance of the 
stroma.
The incidence of endometrial polypi throughout 
the post-menopausal years from 1 to 34 years after 
the menopause, does not suggest progressive 
growth such as might be expected if the polyp 
represented a benign tumour. Thus there is no 
evidence that endometrial polypi of inactive gland 
pattern are examples of active hyperplasia nor yet 
of retrogressive hyperplasia. Nor do they appear 
to be neoplastic in origin. Rather the diffuse 
cystic gland pattern is to be regarded as a 
variant of atrophic endometrium. And polypi would 
appear to be local aggregations of endometrium of 
cystic gland pattern.
SECTION 4
THE RELATIONSHIP OP ENDOMETRIAL HYPERPLASIA TO 
~~.... ........ ‘CARUINUM.  .... "    ~
In most cases of active hyperplasia of the 
post-menopausal endometrium the histological 
appearances are obviously benign. There are 
however a few instances in which the degree of 
activity is such that it may resemble actual 
adenocarcinoma. Novak and Rutledge (1948) have 
recently drawn attention to an atypical form of 
hyperplasia which may be confused with endometrial 
carcinoma. This group of cases is not large but 
the occasional resemblance in gland pattern 
between the two conditions has led to the suggestion 
that they are both the result of the same stimulus. 
If this were so it might be that hyperplasia was a 
precursor of endometrial carcinoma, a relationship 
analogous to that said to exist between cystic 
dysplasia and carcinoma of the breast. From this 
it has been argued that the stimulus responsible 
for the development of hyperplasia, if allowed to 
act for a sufficiently long time, might jjroduce 
malignant change in the endometrium in susceptible 
women.
I do not propose to consider the problem of 
the aetiology of carcinoma of the endometrium 
except in relation to post-menopausal hyperplasia 
of the endometrium. Much of the literature deals 
with the role of hyperplasia of the endometrium 
during the reproductive life or near the menopause. 
But hyperplasia of the reproductive era is a 
reversible process and thus differs from the 
condition as it is found after the menopause.
It has been shown that functional disturbance 
of the uterus in the post-menopausal phase is 
associated with a marked increase in the incidence 
of endometrial hyperplasia. A study of patients 
with granulosa cell tumours of the ovary and of 
post-menopausal women receiving oestrogen therapy 
has indicated that the changes found in patients 
suffering from functional haemorrhage may also be 
related to oestrogens. This suggests several 
possible lines of investigation into the problem 
of the relationship of endometrial hyperplasia to 
carcinoma. A number of authors have tried to 
relate the type of endometrium existing in the 
post-menopausal period to the subsequent 
development of carcinoma. Hertig and Sommers
(1949) reported the finding of endometrial hyper­
plasia in a number of cases where curettage had 
been performed a number of years prior to the 
discovery of carcinoma. Burch (1934) on the other 
hand states that he has never observed hyperplasia 
associated with or as foierunner of carcinoma of 
the endometrium. Indirect evidence of a hyper­
plastic process, probably related to oestrogen 
stimulation has been reported by Ayre and Bauld 
(1946) who studied the changes in vaginal smears 
in cases of uterine carcinoma. As a result of 
clinical investigations Randall (1945) states 
that adenocarcinoma does not occur in the uterus 
of a woman whose vulval and vaginal tissues 
suggest deprivation of oestrogenic hormone.
There are several possible lines of 
investigation of any relationship between endometrial 
hyperplasia and the development of carcinoma.
In the first place examination of material from 
cases of endometrial carcinoma ought to show 
a high incidence of hyperplasia in the uninvolved 
endometrium. Although this has been attempted by 
other writers it is necessary to point out that 
hitherto the normal post-menopausal endometrial
patterns have not been taken into consideration 
when assessing results. Secondly, if cases of 
post-menopausal endometrial hyperplasia are 
studied over a period of years one would expect 
to find the incidence of carcinoma to be greater 
in this group than in the general female population. 
And pursuing this argument in the opposite 
direction, investigation into the type of 
endometrium known to have been present prior to 
the development of endometrial carcinoma should 
show a high incidence of hyperplasia.
Although it has been shown in a previous 
section of the thesis that senile polypi are 
unlikely to be an expression of hyperplasia, 
nevertheless their possible relationship to 
endometrial carcinoma must be considered 
particularity since a number of authors regard 
them as benign tumours.
Hyperplasia preceeding carcinoma.
It has been shown in a previous section of 
the thesis that it is not normal for active 
hyperplasia of the endometrium to be present in 
the post-menopausal woman without producing 
symptoms, particularly haemorrhage. It therefore
seems reasonable to expect that, if endometrial 
carcinoma is in fact proceeded by post-menopausal 
hyperplasia, most patients would have a history 
of long continued intermittent bleeding, 116 cases 
of endometrial carcinoma in post-menopausal women 
were analysed in relation to the duration of 
bleeding before the discovery of carcinoma.
Table 21
Duration of bleeding in cases of endometrial carcinoma.
Duration of 
Breeding.
No. of 
Cases Percentage
Under 6 months 60 51.7
6 months - 1 year 34 29.3
1 year - 3 years 20 17.2
Over 3 years 2 1.7
It will be seen from the above table that in 
more than half the cases bleeding had been present 
for less than six months before curettage revealed 
the presence of carcinoma of the endometrium. In 
several cases the duration of bleeding before the 
diagnosis was made was less than a week. In 
80 per cent, of the total less than one year had 
elapsed from the onset of bleeding until 
gynaecological investigation was carried out.
There were only two cases in which bleeding
had occurred more than three years prior to the 
diagnosis of endometrial carcinoma. In both of 
these cases curettage because of bleeding had been 
performed and active hyperplasia was diagnosed.
It was thus quite common to find that a 
woman some years after the menopause developed bleed­
ing, and when curettage was performed a few weeks 
later endometrial carcinoma was found.
If endometrial carcinoma is occurring in 
the same group of patients who have endometrial 
hyperplasia then one would expect that the tumour 
would develop in patients in an age group in 
reasonably close proximity to that in which hyper­
plasia is most frequently found, An analysis of 
patients with functional bleeding associated with 
hyperplasia relative to the time after the menopause 
when the bleeding occurs is shown in Table 22.
Table 22.
Time after the menopause of bleeding in cases of 
endometrial hyperplasia.
Years after the 
Menopause.
Ho. of
Oases,
1 "  ....i
Percentage,
Under 5 years 50 45.5
6 - 1 0 23 20,9 j
11 - 15 15 1 6 ,3  j
16 - 20 9 a, 2 1t
Over 20' -rears 
.. .. .. ___1
10 9. -i. j 
- - -___ ___ A
A similar analysis of cases of endometrial 
carcinoma is shown in Table 23.
Table 23.
Time after the menopause of bleeding due to carcinoma.
Years after the 
Menopause.
No. of 
Cases Percentage
Under 5 years 29 25
6 - 1 0 32 27.6
11 - 15 15 12.9
16 - 20 17 14.7
Over 20 years 23 19. a
Bleeding occurred from 3 to 44 years after 
the date of the last menstrual period.
It is not essential that the stimulus 
responsible for the original development of 
endometrial carcinoma should persist for an 
indefinite period. In fact it need not necessarily 
be present at the time of the discovery of the 
carcinoma. It would be more logical to look for 
the stimulus or for the forerunner of carcinoma 
some years before the development of malignancy.
In a consideration of the role of endometrial 
hyperplasia in the production of carcinoma 
findings at a prior curettage in the post-menopausal 
era would be of value.
A study of the literature shows that in this 
connection as in others most of the reports of 
hyperplasia refer to patients in the reproductive 
era and some to patients not long past puberty 
(Shaw 1929, and Hirst 1929). Where post-menopausal 
patients only are considered the number of cases 
is restively small. Finding of hyperplasia prior 
to the discovery of endometrial carcinoma is 
reported by Morrin and Max (1939), Horsley (1924), 
Speert and Peightal (1949) and Hertig and Sommers 
(1949). On the other hand Burch (1934) and Taylor 
(1932) did not find any case in a post-menopausal 
women where endometrial cancer had definitely been 
preceeded by hyperplasia as established by 
curettage.
An investigation of 116 cases of endometrial 
carcinoma showed that in only 4 instances had a 
curettage been performed in the post-menopausal 
period before the diagnosis of malignancy was made. 
In 2 patients active hyperplasia of the endometrium 
was discovered 7 years and 6 years respectively 
before carcinoma was found. In neither case was 
X-ray treatment given after the original diagnosis 
of hyperplasia was made. The endometrial pattern
in both cases was quite obviously benign at the 
time of the first curettage. This finding is 
illustrated in Figure 4. In one other instance
curettage, 2 years before the discovery of 
carcinoma, did not produce any endometrium for 
examination. In the remaining case prior curettage 
revealed an inactive glandular pattern in a polyp. 
This finding was made lb years before the discovery 
of carcinoma. In half the cases of endometrial 
carcinoma in which a previous curettage had been 
performed in the post-menopausal period, hyper­
plasia was present at this time# Under four per 
cent, of the total cases of carcinoma, however, 
had had symptoms necessitating curettage. If it 
is accepted that patients without bleeding did not 
have hyperplasia of the endometrium, then the 
incidence of hyperplasia as a precursor of 
endometrial carcinoma is less than two per cent. 
This-finding is in agreement with other reported 
series. Morrin (1944) described 4 such oases 
and Horsley (1924) reported one case but the 
original curettage at which hyperplasia was 
diagnosed was performed only 3 months before 
carcinoma was discovered. It is likely that the
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explanation in this case is provided by Taylor •s 
experience. He found 2 cases of adenocarcinoma 
where hyperplasia had been diagnosed at a previous 
curettage. Further study of the original sections 
however showed that the carcinoma had in actual 
fact been present at the time of the first operation.
Further examples of hyperplasia proceeding 
carcinoma are reported by Corscaden, Fertig and 
Gusberg (1946) - 5 cases and Speert and Peightal 
(1949) 6 cases. The most detailed paper is by 
Hertig and Sommers (1949). They were able to examine 
the endometrium in 32 cases of endometrial carcinoma. 
When the original curettage was performed 15 or 
more years prior to the development of cancer they 
found no endometrial abnormality. Seven cases fell 
into this category. Active cystic hyperplasia which 
occurred 17 times, was found mainly in the 6 - 13 
year period before cancer developed. Adenomatous 
hyperplasia of which there were 19 examples was 
noted for the most part when the original curettage 
had been performed within 5 years of the development 
of endometrial carcinoma. They observed innocent 
polyp formation in 10 instances. It should be 
borne in mind however that 12 of 32 patients were
under the age of 45 years and it seems probable 
that a further number had not yet reached the 
menopause since the authors refer to the fact that 
they observed a decline of ovulatory cycles in 
patients between 40 and 50 years of age. Burch (1934) 
remained adamant that he has never observed hyper­
plasia as a forerunner to endometrial carcinoma.
Thus in all the literature there would not 
appear to be more than 30 authentic cases of post­
menopausal hyperplasia as a forerunner of endometrial 
carcinoma. While previous curettage could only be 
studied in four cases of the present series, the 
very fact that the number exhibiting symptoms and 
requiring operative interference was so small 
indicates a certain measure of agreement with the 
above. If hyperplasia were an important factor in 
the development of carcinoma the incidence in 
previous curettage would be much more striking. 
Follow-up of patients with endometrial hyperplasia.
An alternative method of studying this problem 
was to follow the history of patients known to 
have hyperplasia of the endometrium. It would seem 
that if endometrial hyperplasia was a frequent 
precursor of carcinoma then such an investigation 
would result in the finding of the development of
carcinoma in a proportion of such patients. It 
was decided to include only these patients whose 
history could he followed for a considerable 
number of years. No patients were included in 
which the period of follow-up was less than six 
years and the longest period of observation of a 
patient was 12 years. If carcinoma were to 
develop following hyperplasia in the post-menopausal 
era then it is likely that it would be observed 
in such a period of time.
Fifty eight patients were included in this 
series, and six of them could not be questioned, 
three having died of intercurrent disease and in 
three instances it was impossible to trace the 
patient. Three patients had been treated by 
hysterectomy and are also excluded from the 
analysis.
Of the 49 cases, 35 had been treated by 
curettage alone. There had been no further bleeding 
since operation in 26 of these patients. The 
remaining :nine'- patients had a recurrence of 
bleeding and were subjected to curettage. In 
three cases curettage did not reveal the presence 
of any endometrium and since that time the patients
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have had no farther bleeding. The intervals 
between the finding of active hyperplasia and the 
non-productive curettage were 6 months, 2 years
|
and 5 years respectively* There weredT&xp patients 
in whom bleeding recurred and in whose endometrium 
active hyperplasia was noted on both occasions.
The intervals between the curettages were 3 years in 2 cae< 
and 5 years in -the. 'bther: .two*
One patient' ha d a laparatomy performed 
after the second curettage and a granulosa cell 
tumour of the ovary was found. The second patient 
was aged 75 years and was 25 years after the 
menopause when bleeding was first noticed. At the 
second curettage there was extreme hyperplasia of 
the endometrium but there was no suggestion of 
malignancy. The vaginal lining was thick and 
rugose and the cervix was secreting mucus. All 
the evidence pointed to the fact that the patient’s
genital tract was under the influence of oestrogens
and one’s experience of similar cases suggested |
that there was in all probability a granulosa cell 
tumour of the ovary. The patient, however, was now 
80 years old and laparotomy was not performed. j
In the remaining two cases endometrial carcinoma
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was found three years and seven years after the 
prior curettage at which hyperplasia was diagnosed. 
Search was made in further sections from the 
original blocks but no evidence of carcinoma was 
found in the earlier specimens.
There were nine cases in which a "menopausal 
dose" of X-rays was given to the ovaries after a 
diagnosis of post-menopausal hyperplasia of the 
endometrium had been established. Eight of these 
patients remained symptom free but the remaining 
Patient had a recurrence of bleeding seven years 
afterwards. Curettage was performed and thickened 
endometrium was obtained. Histological examination 
revealed an inactive cystic glandular pattern of 
the endometrium.
In five cases active hyperplasia of the 
endometrium, discovered in the post-menopausal 
period, was treated by intra-uterine radium, the 
dosage ranging from 1,600 to 2,000 milligrammes - 
hours. Hour of the patients had no further 
bleeding but in the remaining instance a recurrence 
of bleeding was noted three years later.
Diagnostic curettage did not produce any endometrium 
for histological examination.
Thus 49 patients known to have had post­
menopausal bleeding associated with active hyper­
plasia of the endometrium were observed for periods 
of from 6 to 12 years. Recurrence of bleeding 
occurred in eleven patients. In four cases no 
endometrium m s obtai ned when subsequent curettage 
was performed. An inactive gland pattern was 
present in one instance. There were fix® examples 
of active hyperplasia, in one patient laparotomy 
revealed a granulosa cell tumour. There was 
strong presumptive evidence of a similar tumour 
in t>ne .other patient but her general condition was 
unsatisfactory and laparotomy was not undertaken. 
There were two instances of the development of 
endometrial carcinoma in patients who were known to 
have had post-menopausal bleeding some years 
previously and where endometrial hyperplasia had 
been diagnosed. Hintze (1929) in a follow-up of 
24 cases of post-menopausal endometrial hyperplasia 
associated with bleeding did not find any evidence 
of carcinoma. The original treatment of the above 
patients had consisted solely of dilatation and 
curettage.
Vaezy (1946) found 6 cases of endometrial
carcinoma in a follow-up study of 520 cases of 
active hyperplasia. Not all of the patients were 
post-menopausal hut the eight cases occurred in 
patients aged 49-60 years among 364 patients in 
that age group, an incidence of 2.1 per cent. The 
duration of observation of these patients was 
from five to fifteen years, Payne (1937) considered 
that the absence of bleeding for from one to twelve 
years warranted the assumption that malignancy had 
not developed. Winter (1950) in a study of 76 3 
cases of active hyperplasia found seven cases of 
endometrial carcinoma an incidence of 1,44 per cent. 
He could not find any example of transition from 
endometrial hyperplasia to carcinoma. The 
incidence in the present series is 4.1 per cent.
This is a higher incidence than that noted 
previously by other authors and might suggest 
some relationship between post-menopausal hyper­
plasia of the endometrium and carcinoma. It is 
probable however that the reason for the higher 
figure obtained in this series lies in the fact 
that a smaller number of cases was investigated. 
Moreover all the patients in the present 
investigation had experienced a definite menopause
with amenorrhoea for at least a year before the 
recurrence of bleeding associated with endometrial 
hyperplasia. Nevertheless even if the above 
figure of 4.1 per cent, is correct it provides no 
evidence for any close relationship between 
endometrial hyperplasia and carcinoma. The incidence 
of carcinoma of the corpus uteri in cases of post­
menopausal bleeding from whatever source is 6,9 
per cent. If endometrial hyperplasia was an 
aetiologieal factor in the causation of carcinoma one 
would expect that in any consideEble series of 
cases of post-menopausal bleeding due to hyperplasia 
one would not expect the subsequent development of 
carcinoma to be 4.1 per cent, of cases, that is, 
less than half the general incidence in all cases 
of post-menopausal bleeding. On the contrary one 
would expect the figure to be much higher than that 
found in cases of post-menopausal bleeding 
irrespective of the cause, namely 6.9 pan cent. 
Hyperplasia in association with carcinoma*
In the early stages endometrial carcinoma is 
usually localised to a small area of the lining 
of the uterus. The rest of the endometrium is 
commonly involved at a rate which depends upon the
degree of malignancy of the tumour. There are 
many cases of adenocarcinoma however in which the 
gross lesion seems definitely circumscribed 
involving only a small area of the endometrial 
surface. In this group must he included a number 
of cases in which the carcinoma begins in the form 
of a localised polypoid growth in same portion of 
the uterine cavity, A study of the uninvolved 
endometrium would give information about the 
endometrial pattern found in association with 
endometrial carcinoma.
The literature contains many references to 
cases in which endometrial hyperplasia was found 
simultaneously with adenocarcinoma. A critical 
study makes it clear that in the majority of cases 
both hyperplasia and carcinoma occurred during 
the reproductive life of the woman or actually 
at the time of the menopause. Indeed in some 
instances the hyperplasia was diagnosed not long 
after puberty (Jones and Brewer, 1941? Hirst, 1929; 
Hagzhla, 193b), The number of cases reported in 
which carcinoma was associated ¥/ith hyperplastic 
changes in the uninvolved endometrium after a 
definite cessation of menstruation is much smaller
(Myer, 1922; Taylor, 1932; Novak and Yui, 1936
and Herrell, 1939). Similar studies by a number 
of investigators have led to directly opposite 
results (Cullen, 1900; Heurlin, 1911* Fluhman and 
Stephenson, 1929; and Fahlund and Broders, 1941).
Study of the uninvolved endometrium was 
.possible in 56 out of 116 oases of endometrial 
carcinoma. In a number of cases the diagnosis was 
made from a study of curettinga but for the most 
part the uninvolved endometrium was found in 
hysterectomy specimens. In 26 cases a cystic gland 
pattern was found and in 10 instances this took the 
form of a solitary polyp. There were 24 instances 
where the associated endometrium was noted to be 
atrophic. In five occasions (6,9 P®r cent, of the 
total) the association of endometrial hyperplasia 
and carcinoma was encountered. : In the remaining 
instance a fibro adenomatous polyp was present in 
the endometrial cavity.
The association of the inactive gland 
pattern with endometrial carcinoma is well 
illustrated in Fig. 12. Fig, 13 and 14 are taken 
from a hysterectomy specimen.
Figure 11.
By
Endometrial carcinoma associated with inactive 
dilated gland pattern - diffuse.
H & S x 30
Figure 12.
Endometrial carcinoma associated with senile polyp 
of similar histological pattern to above.
H & E x 15
Figure 13,
Endometrial carcinoma — area indicated in Fig, 13 under 
higher power magnification,
H & E x 75.
Endometrial carcinoma associated with senile polyp - 
hysterectomy specimen.
H & S z 4-
Figure 14.
Figure 15*
Uninvolved endometrium from the same case, showing 
atrophic features.
H & E x 60
Endometrial carcinoma. 
H & S x 60
Figure 16.
.Figure 17,
Endometrial carcinoma in association with cystic
glandular-hyperplasia.
E & E x 75
Meyer (1922) was the first to describe the 
occurrence of islands of cancer in areas of hyper­
plasia in four cases and the description follows 
closely the appearance in three of the five cases 
in the present series. Novak and Yui (1936) in a 
study of the uninvolved endometrium found it to be 
hyperplastic in no less than 40 per cent, of cases. 
This represents an incidence almost five times 
greater than that found in the.cases I have studied. 
The diagnosis of hyperplasia in their cases was 
based on the finding of a "Swiss-cheese" pattern 
of the glands. In the discussion following the 
paper this interpretation of hyperplasia was 
criticised by Te Linde and Healy who suggested 
that many of the speciBiens designated hyperplasia 
were in fact inactive. Certainly some of the 
microphotographs illustrating this point show 
cystic dilated glands of an inactive type. Taylor 
(1932), reported four cases of endometrial carcinoma 
in postmenopausal women found in association with 
"proliferative" changes in the endometrium. In two 
of these cases, however, he refers to the numerous, 
very thin walled cystic glands which very strongly
suggests that these represent the inactive cystic 
pattern referred to above.
Payne (1937) found the association of hyper­
plasia and carcinoma five times as often in the 
post-menopausal as in the pre-menopausal group, 
but the same criticism applies to his criteria for 
the diagnosis of endometrial hyperplasia. It would 
seem that the gland size per se was adopted as a 
criterion in the diagnosis of hyperplasia of the 
endometrium. The histological appearance of 
inactivity in the gland and stroma cells was 
apparently overlooked. The crux of the matter is 
the significance to be attached to the cystic 
dilated gland pattern.
Pahlund and Broders (1941) and Heurlin (1911) 
found the uninvolved endometrium to be atrophic. 
Jo.nes and Brewer (1941) found no evidence of 
oestrogenic stimulation of the endometrium in 
similar cases but in a number of their cases they 
observed a proportion of cystic dilated glands.
The association of hyperplasia and carcinoma was 
noted only once in 23 cases of endometrial carcinoma 
by Fluhman and Stephenson (1929) an incidence 
approximately the same as in the present series.
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Thus it would appear that the endometrium 
found in association with endometrial carcinoma 
in the post-menopausal woman is in 90 per cent.of 
cases atrophic, with cystic dilated glands in 
approximately half the cases. In less than 10 per 
cent, of cases was hyperplasia of the uninvolved 
endometrium found.
In addition it was shown in the section 
dealing with hyperplasia that there was no 
statistical relationship between hyperplasia and 
the inactive gland pattern. It is apparent from 
the description given by the various authors that 
the inactive gland pattern is assumed to be an 
example of hyperplasia, a supposition which has 
been shown to be quite unfounded. It has been 
shown in a previous section of the thesis that this 
pattern normally occurs in 35 per cent, of normal 
post-menopausal women. This fact has not been 
considered by the authors mentioned above and 
would appear to be the cause of the discrepancy 
in the findings reported.
Relationship between endometrial polypi and carcinoma.
The post-menopausal endometrial pattern 
found prior to the development of or in association
with endometrial carcinoma has been considered in 
considerable detail particularity in regard to the 
part played by hyperplasia. The possible relation­
ship between carcinoma and endometrial polypi has 
not so far been dealt with specifically. It has 
been shown in a previous section of the thesis that 
there is no apparent relationship between the 
occurrence of polypi and hyperplasia. In all cases 
the polypi were found in association with an 
otherwise atrophic or inactive endometrium.
A number of authors have suggested that 
carcinoma may develop from endometrial polypi. 
Beattie (1933) in a study of 50 cases of carcinoma 
found two cases (four per cent.) of associated 
endometrial polypi. According to. Stacey (1925) 
five per cent, of patients suffering from 
endometrial carcinoma bad previously had polypi 
removed. In his article however he does not 
distinguish between endometrial and cervical polypi 
and it is impossible to assess the true incidence 
of the former. Hertig and Sommers (1949) 
however, in a study of curettings obtained from 
post-menopausal patients prior to the development 
of carcinoma found polypi in 10 out of 32 cases,
a remarkable incidence of 31.2 per cent. Moreover 
they noted endometrial polypi accompanied 46 
(12 per cent.) of 369 cases of carcinoma. Taylor 
(1932) from a study of cases of carcinoma also 
came to the conclusion that polypi were an 
aetiological factor. The majority of his cases 
were in the reproductive phase of life and therefore 
not comparable with the present series.
It has been stressed in this thesis that the 
general term polyp is a clinical one rather than a 
pathological one indicating a certain histological 
structure. It is therefore necessary to qualify 
the term by indicating the pattern of glands and 
stroma and the degree of activity present. The 
fact that this has not been done in the above 
reports on this subject makes the interpretation 
of their findings difficult.
It has been shown that endometrial polypi 
are local aggregation of endometrial tissue and 
there is no evidence to suggest that senile polypi 
are neoplastic nor that they are related to 
endometrial hyperplasia. It does not appear 
therefore that it would be necessary or helpful 
to assess their significance in the development of
endometrial carcinoma apart from a consideration
of the general endometrial pattern. This problem
has been studied in the previous sections of the
thesis. It is more important in this connection
that the frequent occurrence of such senile
endometrial polypi in normal post-menopausal women
without bleeding is taken into account.
Relationship of oestrogen therapy to development 
of endometrial carcinoma.
Closely associated with the question of hyper­
plasia and its possible relationship to endometrial 
carcinoma is the problem of oestrogenic activity 
in such cases. Although no direct evidence has 
been brought forward, the various authors quoted 
have implied that the development of endometrial 
carcinoma is closely related to the continuous 
action of oestrogen. In this connection the close 
association between the chemical formulae of 
naturally-occurring oestrogens and known carcinogenic 
compounds may be significant. And apart from the 
aetiological significance it is a matter of 
profound clinical interest that long continued 
administration of oestrogen might cause the 
development of endometrial carcinoma. But as has 
been indicated previously there has been no 
convincing evidence that hyperplasia of the post-
menopausal endometrium and carcinoma are closely- 
associated.
Cases of atypical hyperplasia of the endometrium 
strongly suggesting carcinoma in women who have 
been under treatment by oestrogens for long periods 
of time have been reported by Geist, Walker and 
Salmon (1941), Henry (1945) and Clemensen (1946).
Nine cases of actual endometrial cancer have also 
been reported but the direct relationship between 
cause and effect is not of course established. In 
addition in many of the cases reported the patient 
had shown definite evidence of endocrine upset prior 
to the administration of oestrogen. Henry (194 5) 
described an example of a patient who at the age of 
46 had received a menopausal dose of deep X-ray 
because of menorrhagia. Curettage was not, 
however, performed at this time so the possibility 
that the carcinoma, which developed subsequent to 
oestrogen therapy, may have already been present 
at this time cannot be ignored. The case reported 
by Freemont-Smith, Meigs, Graham and Gilbert (1946), 
was of a patient who had many episodes of secondary 
amenorrhoea while still in her thirties.. Treatment 
with Stilboestrol was begun long before the
menopause and a causal relationship to the 
development of endometrial carcinoma is not 
established. Gusberg (1947) reported five cases but 
in three of them there was evidence of functional 
gynaecological disorder, as shown by irregular 
bleeding, prior to the administration of oestrogen.
I have not found a history of prolonged 
administration of oestrogen in any of the 116 cases 
of endometrial carcinoma. The only patient in this 
review who has had such prolonged oestrogen therapy 
had been receiving five milligrammes of 
Stilboestrol daily for two years. The endometrium 
showed active cystic glandular hyperplasia, the 
cervix was secreting actively and there was 
pronounced cornification of the superficial vaginal 
cells. The histological picture was, however, 
quite innocent.
Thus the total number of reported cases in 
this category is small compared with the amount of 
oestrogens administered to patients of this age 
group. It must be observed that, because of 
experience of bleeding associated with oestrogen 
therapy in the post-menopausal women, prolonged, 
uninrerrupted administration of oestrogen is not
now eoimnoniy practised. G-eist (1935) states that 
he has found no evidence to justify the fear that 
carcinoma of the endometrium might result from 
therapeutic use of oestrogen. Zondek (1947) has 
reported that during twenty years clinical 
experience with oestrogenic hormone he has not 
observed an instance in which the hormone had 
produced a malignant tumour. This view is shared 
by Greenblatt and Kuppermann (1947) who considered 
that the evidence of a carcinogenic activity of 
oestrogens in the human female was vague and at 
times only suggestive. Novak (1944) who is a 
protagonist of the theory that post-menopausal 
hyperplasia of the endometrium is a precursor of 
carcinoma, gave as his opinion that no case of 
human cancer has been recorded in which the 
evidence that oestrogen was responsible is 
unimpeachable. It is likely that some confusion 
of ideas has arisen due to the assumption that 
endometrial hyperplasia and oestrogen activity 
are synonymous. In a previous section of the 
thesis it has been shown that oestrogen therapy in 
the post-menopausal period causes hyperplasia 
in phly'34.5bper cent, of cases.
Oestrogen activity in cases of endometrial carcinoma.
Attempts have been made to estimate the amounts
of urinary oestrogen in cases of endometrial 
carcinoma. Herrell (1939) reported the isolation 
of 5 rat units of oestrin in twenty-four hour 
specimens in eight out of ten post-menopausal women 
with adeno-carcinoma of the uterus. Such quantities 
of oestrin however are similar to those found in 
the urine of normal male and female castrated 
patients, (Frank, Goldberger and Salmon, 1936).
It is doubtful if these figures can be considered 
to be accurate. The biological methods of assay 
are at the best a rough assessment of the amount of 
oestrogen present and no reliable chemical method 
has been evolved. The method described by 
Tomnsett (1950) which depends upon a colorimetric 
reading was not found to be at all reliable in 
dealing with the small amounts of oestrogen 
involved in assay in patients past the menopause.
There is no convincing evidence that hyper­
plasia and endometrial carcinoma are associated 
and it has been shown that administration of 
oestrogen does not necessarily result in hyper­
plasia of the endometrium. It is therefore 
necessary to adopt some other technique which
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might provide further evidence of oestrogenic 
activity. For this reason vaginal smears were 
examined from cases of endometrial carcinoma. This 
test is based upon the fact that the proliferation 
of the vaginal epithelium is dependent upon the 
ovarian hormones, particularly the oestrogens.
The decline in ovarian function which occurs in 
the menopausal years thereafter leads to 
progressive thinning of the vaginal epithelium 
until finally in the post-menopausal years and 
in old age, progressive atrophy to even a single 
layer of cells may occur. Where marked oestrogen 
deficiency is present all the cells are from the 
basal layer of the vaginal wall. Leucocytes are 
numerous. Slight oestrogen effect is evidenced 
by the presence of cells from the superficial 
vaginal layer, the cytoplasm of the cells being 
basophilic. When there is a moderate to marked 
oestrogen effect the cells become acidophilic and 
cornification is sometimes present. High 
cornification is suggestive of disordered oestrogenic 
activity in a patient of the post-menopausal years, 
and is sometimes associated with endometrial hyperplasia.
Method
Preparation of Vaginal Smear.
The patient should not douche for at least 
24 hours before the smear is to be taken. A glass 
pipette is introduced into the posterior fornix of 
the vagina, and the vaginal secretion is sucked in. 
The material is expelled on the surface of a 
clean slide and before the smear can dry it is 
fixed in equal parts of 95 per cent, alcohol and 
ether.
Staining- Vaginal Smears.
The Shorr stain has the following formula -
Bielrich Scarlet (Water solution) 0.5 gm.
Orange G. 0.25 gm.
Past Green P.C.P. 0.075 gm.
Aniline Blue (Water solution) 0.04 gm.
Phosphotungstic & Phosphomolybdic 
acid 0.5 gm.
Glacial Acetic Acid 1.0 cc.
Dissolve all completely in 50 per 
cent, ethyl alcohol. 100 cc.
Ayre and Bauld (1946) and Docherty and 
Massey (1945) have found that vaginal smears of 
women with proved malignant disease of the corpus 
of the uterus showed evidence of high activity 
of endogenous oestrogen.
Vaginal smears were obtained from 32 patients 
known to have endometrial carcinoma. Slight 
oestrogen effect was found in 12 cases and oestrogen 
deficiency was present on 1? occasions. Moderate 
oestrogen effect was noted 3 times but there was 
not a single instance in which the oestrogen effect 
could be termed "marked". In no case was there 
cornification of the cells comparable to that found 
in patients known to be receiving oestrogen therapy 
or in a patient who had a granulosa cell tumour 
of the ovary. See Figs. IB and 19.
These findings are contrary to previous 
reports.
It is possible to study this problem on a 
purely clinical basis. In the absence of 
oestrogens the vaginal tissues undergo atrophy 
and in a number of instances the degeneration 
of the tissues proceeds to a point where the 
condition merits the term of atrophic vaginitis.
If increase of oestrogens is an etiological factor 
in the development of carcinoma of the uterus then 
this atrophic condition ought never to occur in 
these cases. A study of the records of 11b cases 
of adeno-carcinoma of the uterus revealed that
Figure 18:,
Vaginal smear from patient with endometrial carcinoma. 
Basophilic squamous cells predominate.
Figure 19.
Vaginal smear from patient T/ho had been receiving oestrogen. 
Eosinophil squamous cells predominate.
atrophic vaginitis was noted in 18 patient’s. This 
is probably a.low estimate of the true incidence 
of atrophic vaginitis in these cases since only 
those cases which were of gross degree would be 
noted in the records of patients suffering from a 
condition of eminently greater importance to the 
individual's health and life.
There is an important clinical bearing to 
this association of an atrophic vaginitis with 
carcinoma of the endometrium which is well 
illustrated by the following three cases. The 
first patient when 22 years past the menopause was 
curetted because of post-menopausal bleeding and 
a senile endometrial polyp with inactive dilated 
glands was removed. Twelve years later she 
complained of further bleeding and a diagnostic 
curettage was indicated. The vagina and the 
vaginal aspect of the cervix showed atrophic 
vaginitis with many minute punctate haemorrhages. 
When the uterine sound was passed through the 
cervical canal the fundus of the uterus was 
perforated and the curettage was abandoned. It 
was considered that the vaginitis was sufficient 
to account for the bleeding of which she complained
and the patient was dismissed from hospital. I 
saw this patient personally three months later and 
admitted her to hospital immediately. Although the 
vaginitis was still present curettage was performed. 
Bulky curettings were obtained and histological 
examination revealed an adenocarcinoma.
In a further case the correct diagnosis of 
endometrial carcinoma was delayed because the 
intense vaginitis complicated by vaginal adhesions 
was regarded as the source of the bleeding.
Curettage was not persisted in when there was 
difficulty in locating- the cervix because of the 
adhesions.
The third case was that of a diabetic patient 
who complained of post-menopausal bleeding. A 
senile vaginitis was present and I had great 
difficulty in locating the canal in a small atrophic 
cervix. I was proposing to desist, considering 
that I had already found an adequate explanation 
for the bleeding. When however I located the 
cervical canal and carried out a curettage, bulky 
friable curettings were obtained from the body of 
the uterus and a diagnosis of carcinoma was established.
It is especially interesting to note that in
a further case a patient had been curetted 6 years 
previously when post-menopausal endometrial 
hyperplasia was found. At the time of the second 
curettage an endometrial polyp showing an inactive 
cystic gland pattern with a small associated area 
of carcinoma was obtained. On this occasion a 
senile vaginitis was present.
Discussion.
Randall (1945) was impressed by the frequency 
with which elderly women with endometrial cancer 
showed a surprisingly well preserved vaginal 
membrane. He considered that adeno-carcinoma did 
not develop in the women having hot flushes, with 
atrophic changes in the vulval and vaginal tissues 
and with no evidence of oestrogen effect on the 
endometrium, uterus and vaginal walls. Corseaden 
(1951) agreed with this view and stated more 
specifically that he had not found adenocarcinoma 
of the uterus in a women who at the same time 
showed an atroj)hic or senile vaginitis. According 
to these writers the vagina in patients with 
endometrial carcinoma has a more youthful 
appearance than one would expect in women well past 
the menopause. There is apparently less atrophy,
less pallor .and thinning of the vaginal lining,
I have several times noticed such a youthful 
appearance of the vagina and cervix in post­
menopausal patients and indeed have for some ti me 
made notes in the operation records of these facts.. 
In not one case was endometrial carcinoma oresent. 
There are 5 outstanding examples of this finding.. 
Twice the condition was present in the patients who 
were receiving oestrogen therapy. In the first 
example the oestrogen was given orally in the form 
of stilboestrol for a period of over two years.
The vaginal smear showed hyper-cornification of the 
squameous cells and there was endometrial hyper­
plasia. In the other case the oestrogen had been 
applied locally in the form of "menopax" ointment 
for the treatment of prufitis. In one other case 
the patient .had a granulosa cell tumour of the 
ovary. In the other two cases not only were the 
vaginal walls healthy but there was abundant 
secretion of mucus from the cervix. Both patients 
had an associated hyperplasia of the endometrium,.
One patient was aged 75 years and Doth hyperplasia 
of the endometrium .and cervical secretion were 
noted in an interval of 5 years.
I have found that an atrophic vaginitis is 
present in an appreciable number of cases of 
endometrial carcinoma. From a clinical point of 
view this association is important. Bleeding is 
usually a symptom of senile vaginitis and while it 
usually takes the form of a blood stained discharge, 
the amount of bleeding may on occasion be quite 
considerable. The assumption that the finding of 
an atrophic vaginitis rules out the possibility 
of endometrial carcinoma is unwarranted and 
dangerous. Even in the presence of an atrophic 
vaginitis, exploration of the uterus is imperative. / 
If this fact is not appreciated errors in diagnosis 
will occur and treatment of carcinoma will be 
delayed. The further importance of this finding 
iif the support it gives for the view that 
oestrogenic activity, as evidenced by the nutrition 
of the vagina, is not a prominent feature in 
endometrial carcinoma.
Summary
1. An investigation of 116 cases of carcinoma of 
the endometrium was made to discover if there 
was any close relationship between the 
condition and hyperplasia of the post-menopausal
endometrium.
Study of the previous history of these patients 
revealed that less than two per cent, had 
previously suffered from post-menopausal hyper­
plasia of the endometrium.
In S.4 per cent, of cases studied the 
uninvolved portion of the endometrium showed 
hyperplasia. An inactive endometrium accounted 
for 91.1 per cent, of the total.
The literature relating to the association 
between endometrial polypi and carcinoma was 
reviewed. As the term "polyp” is a clinical 
rather than a histological one, this question 
was dealt with in a consideration of the 
histological characters of the endometrium and 
of the polyp.
Among the cases in which the endometrium was 
noted to be inactive, a senile polyp wqs 
present in ten instances or 17.9 per cent, of 
the total.
Gases of post-menopausal bleeding were observed 
over a period of six to twelve years. The 
incidence of the development of carcinoma 
subsequent to hyperplasia of the endometriumwas
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4.1 per cent.
7. The literature referring to the occurrence of 
endometrial carcinoma in post-menopausal 
patients having had oestrogen therapy was 
discussed.
b* Indirect evidence of oestrogen activity, namely 
the state of nutrition of the vagina, was sought 
in these cases of carcinoma. In 15.5 per cent, 
of all cases the vagina was found to be atrophic.
9. No convincing evidence was found to support 
the view that endometrial carcinoma develops 
in patients who have had post-menopausal 
hyperplasia of the endometrium, to a greater 
extent than in patients whose endometrium 
shows an inactive pattern.
SUMMARY AND CONCLUSIONS.
An investigation of the endometrial patterns 
found in normal post-menopausal women was 
considered a necessary preliminary to a 
consideration of the problem of functional post­
menopausal bleeding. It was found that contrary 
to general opinion simple atrophy of the endometrium 
was by no means an invariable finding. An inactive 
state of the endometrium, however, did occur in 
98 per cent, of cases. Those cases which were 
histologically inactive could be divided into two 
main groups,namely those of simple atrophy which 
accounted for approximately tw thirds of the 
total, and the remainder in which cystic dilatation 
of the glands was a prominent feature. In rather 
less than half of the cases showing an inactive 
gland pattern the condition was localised to a 
simple portion of the cavity of the uterus in the 
form of an endometrial polyp. None of these 
patterns had any relationship to the age after the 
menopause when they were discovered. Complete 
atrophy of the endometrium had occurred in patients 
one year after the menopause and the cystic gland 
pattern occurred from one to 34 years after the
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cessation of menstruation.
Active hyperplasia of the endometrium was 
found in less than two per cent, of normal post­
menopausal women and when it was present the 
discovery was made in the early years after the 
menopause. This may indicate that active hyper­
plasia in these cases represents a persistence of 
menopausal hyperplasia associated with terminal 
anovulatory cycles. It was not possible, however, 
to obtain a history of excessive or irregular 
menstruation prior to the menopause in patients 
whose endometrium later showed hyperplasia.
In view of the diversity of views on the 
significance of the senile endometrial polyp of a 
cystic gland pattern evidence was sought relating 
to the mode of development of such polyps.* The 
dilated gland pattern has frequently been mistaken 
for hyperplasia although the histological 
appearance is one of inactivity. There was no 
statistical evidence to suggest that there was any 
relationship between active hyperplasia and senile 
polyps. It would seem that these polyps are 
merely a localised form of the diffuse cystic 
gland pattern which is itself a variety of atrophy
of the endometrium. It is significant that a 
senile endometrial polyp is a normal finding in 
the endometrium of one post-menopausal women in 
ten where bleeding has not occurred.
The serious view adopted by gynaecologists of 
the significance of post-menopausal bleeding is 
supported by the finding of malignant disease of 
the uterus and cervix in more than a quarter of 
cases. 7/bare a benign condition was responsible for 
the bleeding there was a local extra-uterine 
source such as decubitus ulceration or polypus of 
the cervix in many cases. Analysis of the 
endometrial pattern showed approximately the same 
incidence of variation as was found in normal post­
menopausal women. And in particular the incidence 
of active hyperplasia was not significantly 
increased. This indicates that the bleeding 
originated from the obvious gynaecological lesion 
and could not be attributed to an altered state
of the endometrium.
In some cases of fibroids of the uterus a 
possible explanation of the bleeding in the post­
menopausal patient was found in the position of 
the fibroid. In the absence of co-existing
endometrial carcinoma or of malignant degeneration 
in the fibroid itself, a submueous situation of the 
fibroid was considered to be a factor. This was 
particularly so when the fibroid had become 
polypoidal. Where, however, the fibroids were 
intra-mural it seemed that bleeding was likely to 
be related to an altered uterine function and the 
increased incidence of hyperplasia was considered 
to be of considerable significance.
The group of cases of post-menopausal bleeding 
referred to as "functional” accounted for 
approximately 25 per cent, of the total. The 
striking feature of this group was the high 
incidence of endometrial hyperplasia which was 
more than ten times as frequent as in normal post­
menopausal women. An important point in this 
connection was that hyperplasia in patients with 
bleeding, in contrast to that found in normal 
women, was not restricted to the early post­
menopausal years. On the contrary active hyper­
plasia in those patients was found as late as 30 
years after the cessation of menstruation. It 
would seem that hyperplasia associated with bleeding 
is not the persistence of a menopausal condition
but frequently arises de novo in elderly women. 
Ih'the majority of such cases curettage results in 
cessation of the bleeding. This may be 
supplemented by deep X-rays to the ovary. Where 
haemorrhage recurs after such treatment the most 
likely cause is the presence of a hitherto 
unsuspected granulose cell tumour of the ovary, 
often so small as to be impalpable.
Although hyperplasia was of frequent 
occurrence in post-menopausal patients with 
bleeding, this symptom was also present in women 
whose endometrium showed atrophy or an inactive 
cystic gland pattern. There was, however , no 
increase in the incidence of the inactive gland 
pattern, either of the diffuse type o f where the 
pattern was confined to a polyp, compared with 
the incidence in normal post-menopausal women.
It did not seem that this pattern was responsible 
for the occurrence of bleeding and it is lately 
that the discovery in most cases was accidental. 
The histological structure of the polyps, however, 
indicated that haemorrhage might result from very
slight trauma.
The dilated gland pattern has frequently
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been mistaken for hyperplasia although as has been 
shown, there is no relationship between the two 
conditions. This has resulted in their 
incrimination as a cause of post-menopausal bleeding. 
As a result of erroneous diagnosis of hyperplasia 
or because of the supposed. relationship between 
the two conditions some of the patients concerned 
have been subjected to hysterectomy. In fact 
curettage in addition to supplying the diagnosis 
constitutes effective treatment. The administration 
of deep X-rays to the ovaries is neither logical 
or necessary.
RELATIONSHII OF HYPERPLASIA TO ENDOMETKIAL CARCINOMA
It was found that there was no evidence that 
endometrial carcinoma is closely related to the 
occurrence of post-menopausal hyperplasia of the 
endometrium. This is contrary to general opinion 
and the reasons for accepting- this view may he 
stated as follows. Most of the cases reported in 
the literature in which endometrial carcinoma was 
noted to follow hyperplasia occurred during the 
reproductive life. In the cases occurring after 
the menopause most authors have assumed that in 
elderly women the endometrium undergoes simple 
atrophic change. Herein lies the importance of 
the study of endometriums of normal post-menopausal 
women. This investigation, as has been stated, 
showed that cystic dilated glands frequently occur 
in the normal post-menopausal endometrium. Many 
writers have not taken this fact into consideration 
and others have regarded the presence of dilated 
glands as evidence of hyperplasia, either active 
or retrogressive. This is especially true of 
senile polyps which have an inactive appearance 
and are properly to "be classified with atrophic 
endometrium.
Thus it would appear that many writers have 
been impressed by the frequent association of an 
endometrium showing dilated glands with endometrial 
carcinoma. This they interpreted as being evidence 
of co-existing hyperplasia and carcinoma, or hyper­
plasia preceeding the development of malignancy.
From this it was argued that the two conditions arose 
as a result of a common stimulus and that endometrial 
hyperplasia was a precursor of carcinoma of the 
corpus uteri. The frequent finding of a cystic 
gland pattern is confirmed in the present investigation 
but such an association is only logical when it is 
remembered that this variety of atrophy of the 
endometrium occurs under normal conditions in one 
third of post-menopausal women. This argument 
applies with equal force to the association between 
senile endometrial polypi of similar gland pattern 
with endometrial carcinoma.
The view that there was no close relationship 
between the two conditions of the endometrium, 
hyperplasia and carcinoma, received support from 
a study of cases of hyperplasia over a period of 
years. It was found that the occurrence of 
malignancy in an endometrium known to have been
hyperplastic was so infrequent as to suggest that 
it was a fortuitous circumstance likely to be 
noted in a consideration of any two commonly 
occurring abnormalities.
The importance of this interpretation is twofold. 
To the clinician dealing with a post-menopausal 
patient with bleeding where the endometrium shows 
active hyperplasia the problem is simple. If 
endometrial carcinoma is liable to follow active 
hyperplasia in an appreciable number of cases then 
nothing short of complete extirpation of the uterus 
will constitute adequate treatment. If, however, 
there is little likelihood of such an occurrence, 
then the correct treatment is that which will 
produce cessation of the bleeding. In many cases 
curettage alone results in cure of the symptoms.
Some gynaecologists because of the known action 
of oestrogens in producing hyperplasia supplement 
this with X-ray treatment to the ovaries on the 
assumption that these organs are the source of 
the hormone. There can be no comparison between 
the severity of the effects of curettage and of 
total abdominal hysterectomy in patienis of this 
age group. These elderly women are more likely to
have high blood pressure, impaired kidney function 
and diminished cardiac reserve. They are m o r e  
liable to pulmonary congestion and thrombophlebitis 
with embolism. And in spite of the advances of 
modern anaesthesia with general supportive measures 
total hysterectomy is in such patients a formidable 
operation. In the presence of a malignant condition 
of the uterus the added risks are accepted, but in 
the absence of endometrial carcinoma or the 
probability of its development such radical 
treatment is unnecessary.
The second consideration is the role of 
oestrogens in the production of endometrial 
carcinoma. Oestrogens are known to produce 
hyperplasia of the endometrium and if this condition 
were a precursor of carcinoma then the possibility 
of oestrogens being concerned in the aetiology 
of the malignant condition would arise. This 
again is a matter of vital interest to the clinician. 
Oestrogens are used in the treatment of atrophic 
conditions of the vagina and vulva of post­
menopausal women. The hazard of bleeding from 
the endometrium during the course of the treatment
must be accepted and the patient should be warned 
of such a possibility. But, every clinician would 
hesitate to use a substance which, might produce 
a malignant condition of the endometrium. In 
spite ot the vast amount of oestrogens which have 
been administered only a very few cases of 
endometrial carcinoma in such circumstances have 
been reported, and the relationship of cause and 
effect was not established.
Finally the occurrence of endometrial 
carcinoma in post-menopausal patients suffering 
from atrophic vaginitis is reported. From an 
aetiological point of view this suggests that there 
is not in these patients an excess of oestrogen 
acting on the genital tract. The association of 
these two conditions receives scanty attention 
in the literature of the subject. The contrary 
view, that endometrial carcinoma does not occur in 
women whose vagina suggests oestrogen deficiency, 
has been stressed. The clinical implications of 
this are obvious. The presence of an atrophic 
vaginitis, while providing a possible explanation 
of post-menopausal bleeding, should not be 
accepted as indicating that a malignant process
process of the uterus is unlikely to he present. 
The necessity for a thorough exploration of the 
uterine cavity is in no way diminished in these 
cases.
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Xts tracts I 1 o j l l o ase Histories o f .patients with fibroids of the uterus
in a;' O* £?, c< of’ "bsi''ign postmenop?„us al hie eding,.
Age at Type of
Gas e *-g® Menopause Parity Menopause Histological Findings.
Mrs • M. McF. 53 47 4 Normal Atrophic.
Mrs. M.T 55 50 2 !1 Atrophic.
Miss J. McL» 54 50 - I Atrophic.
Mrs. J.T. 56 49 3 If Atrophic.
Mr3 « J.H. 51 49 4 I Atrophic.
Miss M.IT. 62 49 - I Active hyperplasia.
Mrs. J.D. 54 50 - It. Atrophic.
Miss H.B. 64 50
tl Inactive dilated gland.
Mr 3. S.C. 60 52 - II Inactive dilated gland.
Mrs, G.H. 65 52 2 fl Atrophic.
Mrs. R.vV. 45 40 4 X-ray Secretory endometrium.
Miss G. 69 47 - Normal Atrophic.
Miss H. McC. 58 51 -
II Proliferative endometrium
Mrs. 3 • 01H. 53 51 1 1 Atrophic.
Miss H.A. 64 49 -
rt Atrophic.
Mrs. M.R. 60 48 l ti Atrophic.
Mrs. G.H. 58 54 - ti Inactive dilated gland.
Mrs. M.G. 51 46 1
ir Proliferative.
Kiss G.E. 56 47 - M xi.ctive hyperplasia.
Mrs. J.B. 50 49 l
It Secretory endometrium.
Mrs. H.H. 58 47 cJ If Atrophic - fibroid polyp.
164.
OcttS s Age
A^e at
Menopause Parity
Type of
Menopaus e Histological Findings.
Miss 3 . 47 44 - Formal Atrophic.
M s s !7 n 55 51 - ft Inactive dilated yland.
Mrs. G.McF. 66 43 6 ft Atrophic»
Mrs. J.A. 50 41 2 ft Atrophic - fibroid polyp.
Mrs . V; D TT „ 52 51 1 X-ray Atrophic.
Mrs. S • G * 49 48 - Formal Inactive dilated yland.
Mrs. E . D . 55 51 1 Active hyperplasia.
Mrs , J.M. 42 41 - ft Proliferative.
Mrs » A.B. 50 49 2 11 Atrophic.
Mrs. H.B. 59 56 1
tl Atrophic.
Mrs . G.P. 50 49 1
ft Proliferative endometrium
Mrs. F, A. 62 50 1 ft Atrophic - fibroid polyp.
Mrs, D.F. 54 52 - Atrophic.
Mrs. 3  . D . 54 52 2
If Atrophic.
Mrs. R.M. 67 42 1
tl Inactive dilated mland.
Mrs. A  o L . 49 46 2
If Atrophic.
Mrs. R. McL. 54 50 -
It Atrophic.
Mrs. S.R. 56 52 -
tf Atrophic.
Abstract of case histories of Functional Postmenopausal Bleeding-.
Case Age
Age at 
Menopause. Parity
Type of 
Menopause. Histological Findings.
Mrs. McC. 64 55 8 Fatural Ho endometrium obtained
Mrs. P. 51 42 3 II Fibro adenomatous polyp
Mrs. P. 56 47 72 M Active hyperplasia.
Mrs. D. 55 51 5 tt Infected active hyperjl
Mrs. R. 43 41 4 M Secretory endometrium.
Mrs. G. 59 36 2 H No endometrium obtained
Mrs. M. 52 50 1 M No endometrium obtained
Mrs. S. 57 50 2
If No endometrium obtained,
Miss N. 58 51 - No endometrium obtained
Mrs. S. 62 44 6
f? No endometrium obtained.
Mrs. H. 577 50 1
I I No endometrium obtained.
Mrs. McC. 61 45 3
H Active hyperplasia.
Mrs. L. 48 45 5
I t No endometrium obtained.
Mrs. H. 46 29 4 Surgical No endometrium obtained.
Mrs. S. 43 32 4 Surgical No endometrium obtained.
Mrs. R. 60 51 1 X-ray Active hyperplasia.
Recurrence of bleeding 3 years later Active hyperplasia.
Mrs. W . 68 53 7 Natural No endometrium obtained.
Mrs. S. 59 46 5 If No endometrium obtained.
Mrs. A. 51 48 13 If Active hyperplasia.
Mrs. Me I. 50 35 4 ff No endometrium obtained.
Mrs. H. 59 40 5
M Inactive dilated gland.
Mrs. A. 58 45 8
tt No endometrium obtained.
Case
Age at 
Menopause Parity
Type of
Menopause Histological Findings. 
Active hyperplasia.Mrs, D• 48 42 2 Natural
Mrs, P. 61 46 5 X-ray Active hyperplasia.
CQ 61 51 6 Natural Active hyperplasia.
Mrs, M, 55 47 5 ! ? No endometrium obtained
Mrs» G . 65 45 8 If Inactive dilated gland.
Mrs, L» 61 50 2 It Atrophic endometrium.
Mrs» F„ 55 48 2 If Atrophic endometrium.
Firs, G, 64 50 9 ft Inactive dilated gland.
Mrs. P. 62 45 1 II Inactive dilated gland.
Mrs o  J, 62 50 4 It Inactive dilated gland.
Mrs. D. 52 49 4 X-ray Active hyperplasia.
Curettage at time of menopause -- scanty curettings.
Mrs. W. 58 50 4 Natural Atrophy.
Mrs, B, 61 50 2 tt No endometrium obtained.
•Miss M. 54 49 - It No endometrium obtained.
Mrs, P. 57 50 1 II No endometrium obtained.
Mrs, M, 57 50 5 tl No endometrium obtained.
Mrs. D. 42 40 3 X-ray No endometrium obtained.
Mrs, W. 60 45 8 Natural Atrophy.
Mrs. S. 57 45 6 II No endometrium obtained.
Mrs, B, 51 49 12 ft Active hyperplasia.
Mrs. G, 69 55 5 If No endometrium obtained.
Mrs. B. 52 43 4 ft No endometrium obtained.
Mrs, B, 69 47 7 If Inactive dilated gland.
it y.
Case Age
Age at 
Menopause Parity
Type of 
Menopause Histological Findings.
Mrs. I. 50 48 2 Natural Active hyperplasia.
Mrs. S. 50 47 1 Tt No endometrium obtained.
Mrs. T. 53 50 4 T» No endometrium obtained.
Mrs, G • 54 50 3 i t Active hyperplasia.
Previous curettage - metropathia haemorrhagica
Mrs, B. 60 45 7 Natural No endometrium obtained.
Mrs. E. 61 38 - If Inactive gland pattern.
Mrs. A. 58 40 - tt Active hyperplasia.
Mrs. L. 50 47 4 If No endometrium obtained.
Mrs. Me P. 66 46 1 fl No endometrium obtained.
Miss So 53 49 - Radium Inactive gland pattern.
Mrs. G. 52 49 3 Natural Active hyperplasia.
Mrs . S« 48 40 4 II No endometrium obtained.
Mrs. H. 44 41 3 I Atrophic endometrium.
Mrs. Mae P. 62 52 3 If Inactive gland pattern.
Mrs. Y. 57 45 4 f! No endometrium obtained.
Mrs. M. 47 45 1 I? Prolif erative.
Mrs. S. 55 52 - t! P’ibro adenomatous polyp.
Mrs. D. 51 47 3 IT Active hyperplasia.
Mrs. I. 69 45 2 If No endometrium obtained.
Mrs. M. 62 50 1 It Active hyperplasia.
Mrs. I.M. 60 47 9 IT No endometrium obtained.
Mrs . B.R. 67 43 8 t! No endometrium obtained.
Mrs . E.H. 57 50 5
It No endometrium obtained.
Mrs, S.H. 54 51 2
ft Atrophic endometrium.
Age at Type of
Cas 3 M l Menopause Parity Menopause
Mrs. A.F. 62 49 3 Natural
Mrs. c ,w. 58 48 3 ft
Mrs. M.W. 52 51 71 ti
Mrs. tT.  I « 59 50 4 tt
Mrs. J.L. 50 43 4 if
Mrs, E.A. 46 43 2 f!
Mrs« M.H. 48 38 6 If
Mrs. I.D. 56 50 3 ft
Mrs. M.W. 64 42 2 I!
Miss I.T. 64 40 - If
Mrs. C.G. 44 40 8 Surgical
Mrs. A.K. 52 51 10 Natural
Mrs * S.D. 54 40 11 II
Hits . A. A. 70 46 5 tt
Mrs, J.F. 49 29 2 Surgical
Mrs. C. A. 67 42 2 Natural
Mrs. M.S. 57 45 6 II
Mrs. E.G. 52 51 2 ft
Mrs.M.McT. 54 52 3 tl
Mrs. A.D. 52 •£» Oo 3 tt
Mrs, N.M. 50 46 9 It
Miss M.C. 77 46 - ft
Mrs. G.E. 57 38 -
tl
Mrs,M.McG. 61 55 2 ft
Recurrence of "bleeding 2 years later
Histological Findings.
No endometrium obtained.
Active hyperplasia.
No endometrium obtained.
No endometrium obtained.
No endometrium obtained.
No endometrium obtained.
No endometrium obtained.
Infected atrophic endometrium,
Active hyperplasia.
No endometrium obtained.
Atrophic endometrium.
No endometrium obtained.
No endometrium obtained.
Infected inactive cystic glanc
No endometrium obtained.
Atrophic endometrium.
No endometrium obtained.
Atrophic endometrium.
No endometrium obtained.
No endometrium obtained.
No endometrium obtained.
No endometrium obtained.
No endometrium obtained.
Active hyperplasia.
No endometrium.
169.
Ca;se Age
Age at 
Menopause Far it ;y
Type of 
Menopausi
Mrs. F. McC. 60 45 4 Natural
Recurrence of bleeding 6 months later
Mrs. A. V. 52 46 3 Natural
Mrs. A.O. 70 50 *>0 tl
Mrs. n 61 48 4 »»
Mrs. A.L. 53 44 Surgical
Mss S.K. 67 :4i - Natural
Mrs. J.I. 46 34 1 T!
Mrs. M.S. 54 52 9 t
Mrs. M.M. 58 52 0C, f f
Mrs. J.P. 70 50 4 ft
(4 years later1 admitted because of twisted
cyst - found to be a granulosa cell tumou:
Mrs. E.M. 63 43 6 Natural
Mrs. M. Me I. 72 50 tt
Mrs , J.K, 51 40 - tl
Mrs. M.W. 56 39 4 t
Mrs. M. Me I, 56 46 6 II
Mrs . M.B. 55 54 EJ It
Mrs, E. MeI. 47 46 1 tt
Miss E.C, 52 49 - :»
Mrs. C.R. 48 46 4 t!
Mrs. C. A. 60 40 - tt
Mrs, J, J. 60 48 5 + 1 tt
Active hyperplasia.
No endometrium.
Secretory.
Atrophic endometrijim. 
Active hyperplasia. 
Inactive dilated gland. 
Active hyperplasia.
No endometrium.
No endometrium.
Atrophic endometrium. 
Infected active hyperplas
Atrophic endometrium.
Atrophic endometrium.
Atrophic endometrium.
Atrophic endometrium.
Active hyperplasia.
Atrophic endometrium.
Secretory endometrium.
Inactive dilated gland,
Froliferative endometrium
IIo endometrium.
Infected atrophic 
endometrium.
170.
Case Age
Age at 
Menopause Parity
Type of 
Menopause Histological Findings.
Mrs. M.C. 50 49 - Natural Active hyperplasia.
Mrs. M.R. 98 48 9 If No endometrium.
Miss T &JL « O q 69 40 - If No endometrium.
Mrs, EoB. 61 94 9c. X-ray Atrophic endometrium.
Mrs. A, McC. 50 46 4 Natural Active hyperplasia.
(Treated by Radium. 5 years later curettage befens repair - no endometrium).
Mrs, M.L. 99 49 9 Natural No endometrium.
Mrs. P.P. 60 90 3 If No endometrium.
Mrs. nA' © 98 48 - If Infected inactive dilated 
gland.
Mrs. T. 92 48 1 I Proliferative endometrium 
infected.
Mrs. A.H. 93 47 - If No endometrium.
Firs, T p  n 69 47 10 IT Inactive cystic gland.
(Two yes,rs later recurrence of bleedingr^Active hyperplasia).
Mrs. S. Me P. 90 49 • 3 Radium No endometrium.
Mrs. M. McC. 74 47 - Natural Active hyperplasia.
Mrs. B. 47 49 -
II No endometrium.
Mrs, M.K. 99 92 1
If Inactive d i1ated glands.
Mrs. E. McC. 98 48 3
It No endometrium.
Mrs. H.Q. 61 42 6
If Atrophic endometrium.
Mrs. 3.L. 62 1 90
If Atrophic endometrium.
Mrs o I.B. 66 46 9
ri No endometrium.
Mrs. A.B. 93 46 1
if No endometrium.
Mrs. B.L. 48 37 1
if No endometrium.
171
Age at Type of
Case Age Menopause Parity Menopause
Mrs. D.S. 70 50 6 Natural Inactive gland pattern
Mrs. J.C. 49 45 6 ft Infected inactive glam 
pattern.
Mrs . J.H. 43 40 2 r? Active hyperplasia.
Mrs. St. I. 54 50 2 Tf No endometrium.
Mrs. B • W • 61 34 1 »l No endometrium.
Mrs. H. McL. 79 50 4
ft No endometrium.
Mrs. S.H. 53 46 1 X-ray No endometrium.
Mrs. J.M. 54 50 5 Natural Active hyperplasia.
Mrs. U  9 O* 58 48 -
ft Active hyperplasia.
(3 yrs. later had recurrence of bleeding - adenocarcinoma).
Mrs. T  H 65 50 11 Natural Active hyperplasia.
Mrs, P.P. 60 50 9
If No endometrium.
Mrs. G.B. 59 49 7
tt No endometrium.
Mrs. M.W. 54 51 -
tl Atrophic endometrium.
Mrs. E.7M 62 48 OC-
ft Active hyperplasia.
(7 years later recurrence of Bleeding- - endometrial carcinoma),
Mrs. H.T. 63 52 5 Natural Active hyperplasia.
Mrs. H.*V, 51 46 1
If Active hyperplasia.
Mrs. E.W. 69 40 6
ft Ho endometrium.
Mrs. E.3. 57 50 9
ft No endometrium.
Mrs. C.F. 59 50 2
ft No endometrium.
Mrs. R.W. 59 47 -
tl Inactive dilated gland.
Mrs. 3.L. 65 47 2
tl No endometrium.
172.
Age at Type of
CuS0 Aye Menopause Parity Menopause Histological Findings.
Mrs • C. McD. 52 50 4 Natural No endometrium.
Mrs. S , <V. 73 50 1 ti Active hyperplasia.
Mrs. R.W. 59 50 1
tr Active hyperplasia.
Mrs. D .  A . 52 51 7 f Proliferative endometrium.
Mrs. E . B „ 63 45 3
f! Fibro adenomatous polyp.
Mrs. A.T. 58 50 - ff No endometrium.
Mrs. H. McC. 59 47 4
It No endometrium.
Mrs. C.A. 71 50 9
If Inactive dilated glands.
Mrs. A.C. 54 46 2
tr Active hyperplasia.
Mrs. J.B. 62 42 -
ft Fibro adenomatous polyp.
Mrs. C.L. 51 49 1
if Atrophic endometrium.
Mrs. R.T. 57 30 2
it No endometrium.
Mrs. A. S. 57 50 3
it No endometrium.
Mrs. I. McN. 51 49 2
ft Infected atrophic endometriu
Mrs. B». 47 43 2
ti Atrophic endometrium.
Mrs. J.G. 51 40
3J
it No endometrium.
Mrs. C.McD. 67 47 6
n Active hyperplasia.
Mrs . A  Q  ti.O. 54 46 1
it No endometrium.
Mrs. B.P. 45 42 6
ri Active hyperplasia.
Mrs. o.D. 52 48 -
it No endometrium.
Miss 2± 9  &  9 54 49 -
ft Fibro adenomatous polyp.
Mrs. A. McM. 61 50 4
if Inactive dilated gland.
Mrs. 8 .  B . 58 48 1
n Active hyperplasia.
Mrs. C.B. 50 48 2
it Active hyperplasia.
173.
Age at Tyre of
C A!se Age Alenopause Parity Alenopause Histological Findings.
Mrs. A. Vi/. 61 47 2 Natural Active hyperplasia.
Mrs. W.P, 73 48 2 1 Inactive dilated gland.
Mrs. H.K. 51 47 8 M Active hyperplasia.
Mrs. C.H. 63 50 3 ft No endometrium.
Airs. Ic McF. 68 52 6 il No endometrium.
Mrs. I . E . 73 50 6 If No endometrium.
Miss J .B . 55 50 -
n No endometrium.
Airs. H.M. 58 36 5 it No endometrium.
M rs. C .F . 42 36 2 Surgical Active hyperplasia.
Miss J o Me A. 52 50 - Natural No endometrium.
Airs. a .e . 51 46 4
ff No endometrium.
Mrs o A.F. 75 50 4
1 If Active hyperplasia.
Recurrence 5 years later Active hyperplasia.
Mrs. G.M, 53 47 6 Natural Active hyperplasia.
Mrs. C.H. 69 53 3
ff No endometrium.
Airs . S. McW. 46 40 1
ff No endometrium.
Mrs. L.L. 53 50 4
f f No endometrium.
Airs. I. McC. 64 51 2
ff Fibro adenomatous polyp.
Mrs. H.W. 47 45 2
ff Active hyperplasia.
Mrs. A. W . 52 45 5
ti Atrophic endometrium.
Airs. K.D. 49 46 -
ll No endometrium.
Mrs. J.M. 50 48 3 Radium
Proliferative endometriui
AHiss S.S. 60 48
- Natural No endometrium.
Airs. A. AH. 52 50 4 X-ray
Atrophic endometrium.
174.
Age at Tyre of
Case Age Menopause Parity Menopause
Mrs. A. ^  9 59 47 3 Natural
Mrs. C.W. 80 62 - II
Mrs. A. McB. 60 44 1 II
Mrs. I. MeG. 54 52 4 IF
Mrs. B.A. 54 49 7 It
Mrs. J.M. 50 45 3 ff
Mrs. I.E. 50 49 5 If
Mrs. H.3. 49 45 2 1!
Mrs. S.B. 53 51 - X-ray
Mrs. A O  "9 51 48 1 Natural
Mrs. H.B. 50 45 3 ff
Mrs. H. McC. 63 48 4 It
Mrs. I.W. 59 50 - ff
Mrs. R .  Ac 53 44 2 If
Mrs. A, McG. 52 49 7 ff
Mrs. I I . K . 68 50 3 IT
Mrs. R.W. 44 41 2 If
Mrs. C.A. 72 50 5 II
Mrs. K.B. 54 46 - IT
Miss A.B. 52 50 - ft
Mrs. M.T. 48 41 3 ft
Mrs. J.B. 48 47 1 t:
Mrs. A  .  V*. 51 49 4 Tf
Mrs. C.A. 55 41 2
ft
Mrs. A. S • 49 47 7
II
Inactive gland pattern. 
Active hyperplasia.
No endometrium.
No endometrium.
Atrophic.
Infected atrophic. 
Atrophic.
Inactive dilated gland. 
No endometrium.
Active hyperplasia.
No endometrium.
No endometrium.
No endometrium.
Atrophic.
Atrophic.
Proliferative.
Inactive dilated gland. 
No endometrium.
Inactive dilated gland. 
Active hyperplasia.
No endometrium, 
active hyperplasia. 
Active hyjjerplasia.
No endometrium.
Case ix^e
Age at 
Menopause
iiy'
Parity
Type of 
Menopaus e Histological Findings.
Mrs. A. t b 55 51 3 Natural Active hyperplasia.
Mrs. K.B. 66 50 1 i Inactive dilated gland.
Mrs, V . Xl. . 43 42 3 it Active hyperplasia.
Mrs. n m<J 9 1 0 54 52 9 it No endometrium.
Mrs. H. McC. 60 50 2 n Proliferative endometrium.
Mrs. W.5. 56 44 X-ray Active hyperplasia.
Previous metropathia haemorrhagica 11 years ago.
Mrs. S. McA. 5C 52 6 Natural No endometrium.
Mrs. H.F. 63 45 - If No endometrium.
Mrs. C. McD. 54 50 2 11 Active hyperplasia.
Mrs. A.M. 65 45 4 ff No endometrium.
Mrs. H.T. 69 54 - f! No endometrium.
Mrs. K. McK. 49 47 2 ff No endometrium.
Mrs. R.B. 50 49 8 If No endometrium.
Mrs. A. Y. 53 44 3 fl Active hyperplasia.
Mrs. H.B. 50 49 11 if No endometrium.
Mrs, H.R. 52 51 4 if Atrophy.
Mrs. A.B. 50 45 - f No endometrium.
Mrs . A»-^ s 50 49 5 ff No endometrium.
Mrs. R.H. 55 48 2 it No endometrium.
Mrs. P.M. 52 51 4 X-ray Atrophic endometrium.
Mrs e W.H. 53 51 2 Natural Proliferative.
Mrs. A.M. 62 42 1 ft Active hyperplasia.
Mrs, A. -J. 59 40 5 ff Active hyperplasia.
Mrs. H . M . 65 50 2
It Atrophic endometrium.
176.
Case Age
Age at 
Menopause Parity
Type of
Menopause Histological Finding:
Mrs. HaC0 70 59 1 Natural Infected atrophic 
endometrium.
Mrs. R.R. 57 52 - tr Atrophic endometrium.
Mrs, B. McN a 47 44 4 ?! Infected hyperplasia.
Mrs. G.F. 54 52 2 ?! Active hyperplasia.
Mrs. B.T, 54 50 -
!? No endometrium.
Mrs, G.C. 51 48 7
!? No endometrium,
Mrs, H.T. 54 48 1 X-ray Inactive dilated gland.
Mrs. T.G. 50 49 4 Fatural Atrophic endometrium.
Mrs. S.W. 52 47 3 ?! Secretory endometrium.
Mrs a I. MeFa 68 46 1 ?! Proliferative, endometri
Mrs. H. MeL. 40 36 4 ? ? Secretory endometrium.
Mrs. O 9 B . 51 49 1 !? Secretory endometrium.
Mrs, Ha Me A  a 61 47 7 ?? Atrophic endometrium.
Mrs. Ca MCK. 66 50 3 1! Active hyperplasia.
Miss A  a *V a 42 38 1 li Atrophic endometrium.
Mrs. Aa Me La 57 47 2 ? ? Active hyperplasia.
Miss r yV • 1 e
Hyp
52 51
erplasia in polyp 3
_ U
years previously.
Infected inactive d.ilati 
gland.
Mrs. M.F. 69 42 3 Natural Active hyperplasia.
Mrs, Ha Pa 54 45 4 I! Active hyperplasia.
Mrs. H.G. 57 55 2 f? Atrophic endometrium.
Mrs. M.Ce 54 4P
(Metropathia haemorrhagica 4 years
?f
previously).
Inactive dilated gland.
Mrs. H.R „ 60 48 7 Natural No endometrium.
177.
Age at Type of
Gas e Age Menopause Parity Menopause Histological Findings.
Mrs. M.R. 57 45 2 Natural No endometrium.
Mrs. A. G. 55 52 1 tt Inactive dilated gland.
Mrs , H„H. 66 47 - t? No endometrium.
Mrs. M.M. 58 52 4 n No endometrium.
Mrs. A, McD. 52 48 7 it No endometrium.
Mrs. I .  McC. 52 48 4 if Proliferative endometrium
Mrs. C.G. 54 48 13 fi Atrophic.
Mrs, A, McL. 63 56 - »! No endometrium.
Mrs. J.B. 53 52 5 If Atrophic.
Mrs. H.M. 64 43 4
It No endometrium.
Mrs. M.C. 60 40 2 II No endometrium.
Mrs, I.B. 52 49
r\d tl Active hyperplasia.
Mrs. B.G. 52 50 3
It Active hyperplasia.
Mrs, M.B. 50 54 3
II Atrophic.
Mrs, M.H. 60 42 5 Inactive dilated gland.
Mrs. I .G . 51 47 1
tl Active hyperplasia.
Mrs» H,L. 47 46 l
II No endometrium.
Mrs „ A.McN. 62 51 5
II No endometrium.
Mrs. M.H. 53 42 l
II No endometrium.
Mrs . S.G. 51 45 4
If Inactive dilated gland.
Miss A. A. 53 51 -
tl Active hyperplasia.
Mrs. H.M, 51 44 5
II Proliferative.
Mrs * S.C. 74 47 6
II Inactive dilated gland.
Mrs. A. G„ 53 51 5
It Active hyperplasia.
178
Age at Tvrg cf
Case Age Menopause Parity Menopause Histological Find i n .
Mrs. M.C. 68 46 - Batura1 Inactive dilated y 1and.
Mrs. B.C. 55 49 1 tl Inactive dilated gland.
Mi-s. B.K. 60 46 5 II Inactive dilated gland.
Mrs. H. McC. 71 46 1 ft active hyperplasia.
Mrs. ii. * S . 46 43 1 X-ray Atrophic.
Mrs, M.S. 59 52 1 Natural Bo endometrium.
Mrs. ff f? •Jwu.* a *■ 62 50 2 II Proliferative.
Mrs. I. McM. 49 46 4 It Proliferative.
Mrs. A.B. 71 52 8 It Infseted inactive di1ated
Mrs. S.P. 52 46 J tt Inactive dilated gland.
Mrs. S. K. 58 44 3 II Atrox^hic.
Mrs. H. P. 49 48 3 If Inactive dilated gland.
Mrs. H. A. 54 50 3 It Active hyperplasia.
Mrs. M.C. 56 54 4 ft Atrophic,
Mrs. W.H. 49 47 5 If Bo endometrium.
Mrs. L. McC. 48 44 3 tt Atrophic.
Mrs. W.C. 54 48 - ft B0 e nd ome trium.
Mrs. H.L. 61 52 1 tt Bo endometrium.
Mrs. I.B. 60 50 6 It Inactive dilated gland.
Mrs. C. McK. 48 47 4 tt Bo endometrium.
Miss M.S. 66 28 - It atrophic.
Mrs. 1 . 1 . 53 50 4 ft Proliferative.
Mrs. H.R. 55 50 2
f I Inactive dilated gland.
Mrs. S. McC. 56 J 6 tl Proliferative.
179.
Case Age
Age at 
Menopause Parity
Type of 
Menopause Histological Findings.
Mrs. A.M. 55 40 - Natural Inactive dilated gland.
Mrs. H.M. 52 42 1 tl No endometrium.
Mrs. M.R. 51 45 1 If Active hyperplasia.
Mrs. rj V1 45 43 4 tl No endometrium.
Mrs. H.B. 51 49 4 tl No endometrium.
Mrs. I 4 *J ■ 62 49 6 I Atrophic.
Mrs. V  X} o 51 49 5 I Ho endometrium.
Mrs. K. A. 49 47 3 tt Pro1iferative,
Mrs. J.D. 51 47 1 X-ray Atrophic.
Mrs. K. 56 45 - Natural Inactive dilated gland.
Mrs. J B 54 42 Surgical Atrophic.
y* <q J.F. 52 48 9 Natural Atrophic.
Mrs. E . G . 56 42 2 tr Active hyperplasia.
Mrs o K.B. 49 42 1X t? Atrophic.
Mrs. XT' J? 47 41 “11 It Ho endome trium.
Mrs a J . R . 78 50 8 ft Atrophic.
Mrs. A.M. 49 T J 1 tt No endometrium.
Mrs. a rp A « P . 51 44 2 tt No endometrium.
Mrs. J .  Met*. 60 50 4 if Fihro adenomatous polyp.
Mrs. C.A. 61 53 1 ft Inactive dilated gland.
Mrs. J.M. 62 48 3 ti No endometrium.
Mrs . K. McG. 60 52 1 tt Atrophic.
Mrs. R . C . 53 52 1 ti Infected inactive dilated
Mrs. V  1 '*-l • *< « 51 42 2
11 Proliferative.
Mrs. H.II. CO 51 4 tt No endometrium.
18c.
Age at
Case Age Menopause Parity Menopause
Mrs. A.W. 62 48 2 Hatural
Mrs. H.B. 54 51 71 ii
Mrs. A.C. 55 44 3 tl
Mrs .  E.G. 6C 51 3 tl
Mrs. H.3. 54 50 6 It
Mrs. H.W. 63 47 1 It
Mrs. I.G. 52 49 2 tl
Mrs. S.B. 49 48 4 If
Mrs. H.C. 52 47 2 If
Mrs. H.H. 52 48 3 If
Mrs. a o McK. 61 50 7 tl
Mi’s. H. Me S. 49 39 3 Surgical
Mr s . S. H . 52 48 2 ITatural
Mrs. E.M. 52 50 1 II
Mrs. 3.D. 47 45 4 It
Mrs. H.F, 55 21 2 Surgical
Mrs. E. McC. 59 53 2 It
Mrs. 3,3. 64 45 1!
Mrs .  H.T. 52 45 1 X-ray
Mrs . E, L. 72 52 7 Natural
Mrs. II.Y. 70 50 5 i i
Mrs. H.K. 60 54 3 it
Mrs. A.R. 41 40 2 Surgical
Mrs. H.W. 62 51 4 Natural
Histological Findings. 
Atrophic.
Atrophic.
Inactive dilated gland
Active hyperplasia.
Ho endometrium. 
Infected atrophic. 
Atrophic.
Ho endometrium.
Ho endometrium. 
Proliferative.
Ho endometrium. 
Atrophic.
Proliferative. 
Proliferative.
Active hyperplasia. 
Atrophic.
Inactive gland pattern. 
Atrophic.
Atrophic.
Ho endometrium.
Atrophic.
Inactive dilated gland. 
Inactive dilated gland. 
Inactive dilated gland.
181.
Age at Type of
Gase Age Menopause Parity Menopause Histological Findings.
Mrs. E.W. 59 43 7 Natural Atrophic.
Mrs. J.B. 50 48 3 II No endometrium.
Mrs. R.W. 44 43 3 X-ray Fibro adenomatous polyp.
Mrs. H. McL. 51 48 2 Natural No endometrium.
Mrs. R. A. 47 45 1 II No endometrium.
Mrs. R.W. 64 51 - 1! No endometrium.
Mrs . H.M. 57 54 2 tf Active hyperplasia.
Mrs. E.Lo 60 48 4 ff No endometrium.
ilrs. K.C. 53 51 2 »! Inactive dilated gland.
Mrs. c.c. 54 52 3 tl Atrophic.
Mr 3. H.3. 48 47 2 II Active hyperplasia.
Mrs. A.W. 65 43 1 It Infected active hyperplasia.
Mrs. II. MbD. 51 50 3 tt Atrophy - tuberculosis.
Mrs. H.B. 49 47 3 ft Active hyperplasia.
Mrs. 1?; 0 U * O • 50 49 2 It Atrophic.
Mrs, A. Y. 51 ■ 49 2 ft Atrophic.
Mrs. H.L. 50 49 3 It Froliferative.
Mrs. R.T. 49 47 1 tf Infected proliferative.
Mrs. M.P. 53 51 6 t! Infected active hyperplasia.
Mrs. E.T. 51 , 46 4
tf Atrophic.
Mrs. H.F. 50 48 2 ft Active hyperplasia.
Mrs. I.H. 57 47 8 It No endometrium.
Mrs. A. McC. 58 49 2 tt Infected atrophic.
Mrs. A.M. 54 52 3
tf Atrophic.
Mrs. S.P. 51 42 4 X-ray Inactive dilated gland.
(9 years previously menorrhagia — D. & C« premenstrual endometrium^.
182.
Age at Type of
Case .re Menopause Parity Menopause Histological Findings.
Mrs. E.Il, 51 42 1 X-ray Atrophic.
Mrs . B.C. 63 52 n Natural No endometrium.
Mrs, M. 0. 47 45 3 f! Ho endometrium.
Mrs. R .  ii. 51 46 - tt No end ometrium.
Mrs. A. McC. 53 52 1 tr Atrophic.
Miss A iT*A« o « 64 50 7 tt No endometrium.
Mrs. H.M. 2^ 41 1 tt No endometrium.
Mrs. C.G. 64 49 l tt No endometrium.
Mrs. A.D. 71 50 3 it No endometrium.
Mrs. A.K, 54 52 4 tt No endometrium.
Mrs. I.T. 54 48 - tt No endometrium.
Mrs. E. McC. 48 ■ 46 7 tt No endometrium.
Mrs. R. McL. 57 52 3 tt Atrophic.
Mrs. B.D. 68 45 - if Proliferative tuberculosis.
Mrs. A, McF. 70 42 8 tt Inactive dilated gland.
Mrs. J.L. 48 42 8 tt No endometrium.
Mrs. E « ii. • 63 51 3 Tt No endometrium.
Mrs. M.F. 52 50 1 tf No endometrium.
Mrs. W.G. 57 47 —/ tt Active hyperplasia.
Mrs. L. McB. 54 50 3 ft Inactive dilated gland.
Mrs. H.W. 52 50 1 ! 7 Prolif erative.
Mrs. A .<?. 52 48 2 t t Active hyperplasia.
Mrs . E.F. 50 44 ■j0 tf Infected inactive dilated gland
Mrs. K.A. 60 53 el It Inactive dilated gland.
183.
Case A ge
Age at 
Menopause Paritv
Type of 
Menopause Histological Findings.
Mrs . B.C. 60 50 4 Natural Fibro adenomatous pol
Mrs * W.R. 62 47 1 tl Atrophic tuberculosis
Mrs . P. McC. 64 42 3 rr Ho endometrium.
Mrs, P.P. 55 51 7 tt No endometrium.
Mrs. R.G. 56 51 1 ft No endometrium.
Mrs. G.M. 52 48 - rt No endometrium.
Mrs. K.W. 46 45 4 tt Frolif erative.
Mrs. 3 . ii. 62 47 l tt Inactive dilated glan
Mrs c I.W. 57 52 2 tt Active hyperplasia - 
tuberculosis.
Mrs. E.G. 54 42 4 tt Active hyperplasia.
Mrs. G.P. 55 50 9 it No endometrium.
Mrs. U.S. 57 47 3
tt Active hyperplasia.
Mrs. G.P. 53 50 4 it No endometrium.
Mrs. H.S. 64 50 l it No endometrium.
Mrs » S.S. 72 39 2 tt Atrophic.
Mrs. s. c . 53 51 4 tt Atrophic.
Mrs. R.M. 56 49 2 it active hyperplasia.
Mrs. M. C. 51 50 1
n Atrophic.
Mrs. M.S. 54 53 3
it Fibro adenomatous pol;
Mrs. E.C. 59 44 2
it Inactive dilated glanc
Mrs. I.W. 54 49 5
tt Atrophic.
Mrs. S.R. 48 45 l
tt No endometrium.
Mrs. H.K. 50 49 2
ti Active hyperplasia.
Mrs. E.McP. 64 49 4
tt Active hyperplasia.
184.
Case Age
Age at 
Menopause Parity
Type of 
Menopause Histological Findings,
Mrs „ A. So 61 51 3 Natural Inactive dilated gland.
Mrs. S.s. 52 48 2 rt Atrophic.
Mrs. Ho McE. 72 48 1 ft No endometrium.
Mrs. L.C. 70 50 3 ii Inactive dilated gland.
Mrs * H.F. 58 38 1 X-ray Inactive dilated gland.
Mrs. H. No 61 57 6 Natural Inactive dilated gland.
Mrs „ Ho MeCo 53 47 2 II Atrophic.
Mr 3 . W.3. 72 50 3 II No endometrium.
Mrs o A. Mel, 64 48 1 It No endometrium.
Mrs. H.R. 69 50 4 II atrophic.
Mrs. Co McL. 66 50 2 tt Fihro adenomatous polyp.
Mrs. EoC0 51 47 3 IT Atrophic,
Mrs. M.C. 56 53 I II Atrophic.
Mrs. A. McG. 55 36 2 It Active hyperplasia.
Mrs, E.A. 62 52 4 II Atrophic.
Mrs, M. MeA. 56 49 2 II Fihro adenomatous polyp.
(Curettage one year previously - no endometrium).
Mrs. J .H , 54 50 3 Natural No endometrium.
Mrs'. W.A„ 62 45 1 II No endometrium.
Mrs, J.P. 54 51 1 !T Active hyperplasia.
Mrs. A. McG, 53 50 1 I Infected inactive dilated
Mrs 9 I.M. 53 51 4 If Atrophic.
Mrs« G.E. 55 51 2 I Inactive dilated gland.
Mrs. S.M. 51 47 3 ff Inactive dilated gland.
Mrs. E,H. 52 50 1 I! Atrophic.
185.
CcLS © x ig ©
Age at 
Menopause Parity
Type of 
Menopaus e Histological Findings.
Mrs. I.D. 52 51 3 Natural Active hyperplasia.
Mrs. 3.T. 51 49 3 If Inactive dilated gland.
Mrs. Q.Lo 57 46 o ff active hyperplasia.
Mrs. M.A. 46 39 3 1! Atrophic.
Mrs. v G 54 52 1 II Inactive dilated gland.
Miss A. McP. 78 52 1 M Infected atrophic.
Mrs o JYW. 64 45 3 If No endometrium.
Mrs. E.L. 70 50 3 ft Inactive dilated gland.
Mrs „ G. McL. 67 49 6 ff Inactive dilated gland.
Mrs. A.M. 64 50 5 ff No endometrium.
Mrs. M.T. 48 46 8 ff Atrophic„
Mrs. G.L. 54 43 2 If No endometrium.
Mrs. B. A- 66 51 6 n No endometrium.
Mrs. J.L. 65 53 9 ff Active hyperplasia, infected.
Mrs. A.M. 50 49 9 i i Atrophic.
Mrs. J.C. 60 50 3 i i Active hyperplasia.
Mrs. J. McC. 51 49 4 n Active hyperjjlasia.
Mrs. S.K. 51 49 9 it Active hyperplasia.
Mrs. M.B, 58 48 3 if Atrophic.
Mrs. G.H. 67 49 1 Tf Atrophic.
It'S . E.H. 54 52 6 If Inactive dilated gland.
Mrs. M.B. 68 44 5 II Inactive dilated gland.
Mrs. H. McL. 58 40 - ff No endometrium.
Mrs. E.M. 59 54 2 1 Inactive dilated gland.
Mrs, H.D, 50 45 4 Rad ium Atrophic.
IP 6.
Age at Tvr.e of
Caise Age Menopause Parity Menopause
Mrs. J.G. 54 52 1 Natural
Mrs«. J.C. 6 4 45 9 tt
Mrs „ I.H. 55 52 3 f»
Mrs. J.C. 48 46 3 !
Mrs. H.H, 70 50 - t!
Mrs. G . T . 61 49 4 »t
Mrs. J.G. 51 49 2 n
Mrs. 3 .S. 54 46 4 tt
Mrs . H.O. 60 51 3 tt
Mrs. E . G . 45 42 5 tt
Mrs. J . B . 56 53 3 tt
Mrs. W.H. 54 47 tt
Mrs. A.G. 46 44 4 tt
Mrs . E . S . 64 42 2 !!
Mrs. H . A . 6 0 51 1 tt
Mrs. H. McG. 47 41 1 0 n
Mrs, G . H . 57 50 2 tr
M r s . E . D . 5 6 51 5 it
Mrs. J.M. 50 49 3 tt
Mrs. 3 . C . 54 47 4 tt
Mrs. J . C , 71 33 1 0 tt
Mrs. v nAli9 •> 44 40 1 tt
Mrs. C . H . 62 50 8 tt
Mrs. F.B. 45 42
• r*jL. n
Inactive dilated gland. 
Inactive dilated aland.
Mo endometrium.
No endometrium.
No endometrium.
Fibro adenomatous polyp. 
Atrophic tuberculosis.
No endometrium.
No endometrium.
Secretory.
No endometrium.
Active hyperplasia,
Ac tive hyperplasia.
No endometrium. 
Froliferative.
Fibre adenomatous polyp. 
Inactive dilated gland. 
Active hyperplasia. 
Inactive dilated gland, 
atrophic.
Infected fibro adenomatous 
polyp.
Active hyperplasia.
Active hyperplasia.
187.
Age at
Gas e Age 31enopau.se Parity
Miss W.R. 49 47 -
Mrs. G.H. 62 54 3
Mrs. R.F. 57 50 -
Mrs. H.L. 70 Cf) 1
lira. C.'C. 50 47 7
Miss V.R. RR ^J 52 i
Mrs. M.G. 60 49 1
Mrs. H.B. 60 50 ■>j
Mrs. E.C. 74 47 6
Mrs. 3.H. 58 54 3
Mrs. P.G. 51 45 4
Mrs. H. Me!I. 62 51 5
Mrs, P.H. 49 46 1
Mrs. E.L. 47 46 1
Mrs. J.H. 60 42 RJ
Mrs. S.G. 52 50 3
Mrs. N.C. 55 52 4
Mrs. H.P. 55 49 3
Mrs. P.P. 42 40 2
Mrs. A. J. 58 49 6
Type of
Natural
X-ray 
Rad ium
No endometrium.
No endometrium.
No endometrium.
No endometrium.
Active hyperplasia.
No endometrium.
Inactive dilated gland. 
Active hyperplasia. 
Inactive dilated gland. 
Active hyperplasia. 
Inactive dilated gland, 
atrophy.
No endometrium.
Active hyperplasia, 
active hyperplasia, 
active hyperplasia. 
Inactive dilated gland. 
Inactive dilated gland. 
Decretory.
Fihro adenomatous polyp,
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Abstracts of case histories of patients with endometri
Name.
Age at 
Menopause
Condition Duration 
of of 
vagina Bleeding
Miss J. McM. 63 51 Normal 3 weeks
Miss G.B. 62 42 II 1 yr. 3 mths
Mrs, J.F. 56 52 II 9 months
Mrs . E.I. 56 47 If 5 months
Mrs. H.L. 59 49 tl 1 year
Mrs. A.S. 54 45 II 2 years
Miss p w 69 52 II 5 months
Mrs. 3.H. 76 43 If 2 weeks
Mrs, q  qU  o  J  o 66 46 It 1 month
Mrs. A.M. 63 48 Vaginitis 8 months
Mrs. H.McD. 56 50 Normal 2 years
Mrs. P.R. 63 42 If I month
Mrs. E.G. 58 52 ft 4 months
Mrs. n t■j * © 68 40 II 2 years
Mrs. J.T. 59 50 Vaginitis 1 year
Mrs. M.B. 53 50 Normal 2 months
Mrs. H.T. 62 46 II 7 years
Mrs * M.S. 64 45 Vaginitis 4 months
Mrs. J. McL. 55 50 Vaginitis 5 months
Miss T  1STjU • i« • 57 51 Normal 2 years
Miss T71i-J • • 68 46 I? 2 months
Uninvolved endometrium, 
Inactive dilated gland,
Atrophic.
Atrophic.
Inactive dilated gland. 
Inactive dilated viand.
Atrophy.
Atrophy.
Atrophic. 
atrophic.
Inactive dilated gland
191.
Condition Duration
Name Age .
Age at 
Menopaus'
of
vagina e — ---
of
Bleeding
Uninvolved endometrium
Miss S.B. 63 53 Normal 2 months Atrophic.
Mrs. Q Q kJ • "J e 54 42 ft 8 months -
Miss Ho 3. 70 50 I 3 months Inactive dilated gland.
Mrs. A. MeG. 65 42 I 4 months -
Miss H.G. 60 49 It 8 months -
Mrs . H.S. 58 48 It 3 years Inactive dilated gland.
6 years previously postmenopausal bleeding - active hyperplasia.
Mrs. R.A. 57 53 Normal 3 months -
Mrs. TP T\T ill« ri o 59 47 If 3 weeks -
Mrs. A Wh « 62 48 ft 3 months Inactive dilated gland.
7J years previously postmenopausal bleeding -active hyperplasia.
Miss H.M. 58 50 Vaginitis 8 months Inactive dilated gland.
Mrs. JeM. 60 38 Vaginitis 5 months -
Mrs. I.G. 58 53 Norihal 3 years Fibro adenomatous polyp.
Mrs. I.B. 61 40 ft 4 months Atrophy.
Miss M. McG. 67 50 ri 3 months -
Mrs. V.Y. 54 48 ! I 1 year -
Mrs. HoRo 74 46 I! 3 months Inactive dilated gland.
Mrs , H.G. 53 50 If 10 months -
Jars. S. McD. 62 50 tf 4 months -
Mr 3 . W.S. 68 42 tt 2 weeks Inactive dilated gland .
Mrs . L « A . 75 50 Vaginitis 4 weeks -
Mrs . P.Ho 62 52 Normal 8 months Inactive dilated gland.
192.
Name Age
Age at 
Menopaus e
Condition 
of ' 
Vagina.
Duration
of
Bleeding Uninvolved endometrium.
tiro. w  c*W « >j a 52 49 Normal 9 months Inactive dilated gland.
Mrs. H.P. 48 44 If 2 years Active hyperplasia.
Mrs. H. McL. 70 49 It 3 weeks -
Mrs. *4 « An 65 48 Vaginitis 3 months Atrophic.
Mrs. I. McG. 58 51 Normal 4 weeks Inactive dilated gland.
Mrs. R.Lo 55 48 t 4 months -
Mrs. B. A. 60 39 ft 3 months Atrophic.
Mrs. E.L. 75 40 t 5 months -
Mrs. I.B. 50 Vaginitis 1 month Inactive dilated gland.
Mrs o A. G . 55 35 Normal 5 months ~
Mrs. S . H . 56 49 tt 8 months Atrophic.
Mrs, E.L. 58 50 tt 1 year -
Mrs. H.F. 61 51 tt 3 months -
Mrs. A.T. 57 52 ft 11 months Atrophic.
Miss J. McKo 56 49 Vaginitis 2 years -
Mrs. M.M. 55 52 NorMal 1 year Atrophic.
Mrs. A.S. 62 52 t? 11 months -
£=* M C. MoGo 70 54 IT 2 weeks Inactive dilated gland.
Miss H.M. 60 48 tt 6 months -
Mrs. R.W. 62 42 tt 3 months Atrophic.
Mrs. H.P. 70 53 ft 6 months -
Miss I. McG. 75 40 tt 1 year Atrophic.
Mrs. E.G. 70 45 Vaginitis 4 weeks -
Name A  g e
Age at 
Menopause
193 c
Condition
of
Vagina
Duration 
o£  
Bleeding Uninvolved endometrium.
Mrs. O.Lo 60 50 Normal 8 months Inactive dilated gland.
Mrs. A.Y/. 58 44 tl 11 months Inactive dilated gland.
Miss H.K. 54 46 f t l4 years -
Miss B. McH. 61 17 Vaginitis 6 weeks -
Mrs. H,M, 65 50 Normal 1-3 years -
Mrs . J.H. 47 45 f t Doubtful Atrophy.
(Previous curettings at time of menopaus e - atrophic).
Mrs. A, McN, 57 52 Normal 2 years Inactive dilated gland.
Mrs. H. McL. 53 42 t t 2 weeks -
Miss M. McM. 53 40 Vaginitis 3 weeks Active hyperplasia.
Mrs. J. A. 60 50 Normal 8 months -
Miss A. P. 70 47 f t 6 months Atrophy.
Mrs. J.S. 61 55 t t 6 months -
Nirs. C.M. 66 48 t t 6 months -
Mrs. M.M. 68 32 Vaginitis 5 months Inactive dilated gland.
Miss C.B. 51 47 Normal 2 year3 -
Miss J. M0 60 42 tt 5 months Atrophy.
Mrs. M.S. 55 47 tt 2 months -
Mrs. W.P. 61 52 f t 1 month -
Mrs. A. G. 55 50 t t 3 weeks Inactive dilated gland.
Mrs. J.B. 53 49 tl 9 months Inactive dilated gland.
Mrs. ja.« T . 60 51 ft 4 months -
Miss M.M. 50 35 tt 3 days Atrophic.
194.
Condition Duration 
Age at of of
Name A rj Menopause Vagina Bleeding Uninvolved endometrium.
Miss D.W. 54 40 Vaginitis 7 weeks Inactive dilated gland.
Miss E.G. 76 50 Normal 10 months -
Mrs. S.H. 75 45 Tl 2 years -
Mrs . M.D0 66 52 I 10 months
/
Mr s. A  ^Xin O a 53 46 Tl 2 weeks -
Mrs. A.T. 62 55 Vaginitis 2 weeks -
Mrs. J.H. 61 50 Normal 4 months Inactive dilated gland.
Mrs. I.E. 54 47 II 3 months -
Mrs. J.B. 60 50 It 8 months -
Miss N. McK. 70 50 1! 11 months Atrophy.
Mrs. M. McP. 60 49 Tt 8 months -
Mrs. G.G. 59 47 tl 5 weeks Active hyperplasia.
Mrs. M.MoB. 58 55 n 5 months Atrophic.
Miss H.P. 63 43 tt 8 months Active hyperplasia.
Mrs» L . A. 52 45 tt 4 months -
Mrs. I.M. 64 47 tt 10 months -
Miss M. McK. 72 51 Vaginitis 8 months Inactive dilated gland.
Miss J. S. 59 49 Normal 6 months -
Mrs. C.M. 63 52 tt 4 weeks Atrophy,
Mrs. M. McK. 63 53 tt 2 weeks -
Previous curettage -- inactive dilated gland. pattern.
Mrs. M.B. 58 53 Normal 11 months -
Mrs. B.R. 49 47
tl 3 months Inactive dilated gland.
195.
Condition Duration
name 
Mrs. M.Pc
Mrs. J.Do
Mrs. E.Ho
Mrs. J,Po
Mrs. C.3.
Age at of
Age Menopause Vagina
70
55
57
62
50
49
50 
52 
4ft
of
Bleeding
Normal 10 months 
Vaginitis 5 months
Normal 8 months 
4 months 
10 months
Uninvolved
Atrophy.
Inactive di 
Atrophic.
endometrium.
lated gland.
i
